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ABSTRACT 
Tobacco use is the leading cause of premature death worldwide. To address the growing tobacco 
epidemic, the World Health Organization introduced the Framework Convention on Tobacco 
Control. However, there has been an evolution in tobacco products with flavoured tobacco and 
electronic nicotine delivery systems such as electronic cigarettes (e-cigarettes). Furthermore, the 
tobacco industry continues to disproportionately target vulnerable populations to recruit new 
users. As such, it is critical to be aware of paradigm shifts in Canadian smoking behaviours to 
identify vulnerable populations and to assess the potential harms related to changing smoking 
behaviours. 
When examining flavoured tobacco use the prevalence was elevated among Canadian high 
school students and being males, exposed to peer pressure and having increased weekly spending 
money were identified as significant determinants of flavoured tobacco use.  
The lesbian, gay and bisexual (LGB) population is vulnerable to tobacco use due to intrinsic 
factors, social factors and targeted tobacco advertising. Results of this study showed the 
prevalence of smoking was higher in the Canadian LGB population compared to national rates. 
There was a significant association between sexual orientation and smoking status for lesbians 
and bisexuals compared to heterosexuals, but no significant association between gay and 
bisexuals and heterosexual males. 
Health effects of e-cigarettes have not been well characterized. Using the Canadian Community 
Health Survey, an exploratory study examining the association between past 30-day e-cigarette 
use and chronic obstructive pulmonary disease (COPD) was examined. A sex-based interaction 
effect with female e-cigarette users reporting higher rates of COPD compared to males was 
identified. Furthermore, dual use behaviour was most strongly associated with COPD. 
In the systematic review and meta-analysis examining if e-cigarette use among baseline never 
conventional tobacco users predicted tobacco initiation at follow up, the meta-analysis indicated 
ever e-cigarette users were significantly more likely to initiate tobacco use and current (past 30-
day) tobacco use compared to never e-cigarette users.  
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1. CHAPTER 1: INTRODUCTION TO SMOKING RELATED 
BEHAVIOURS 
1.1 Background 
1.1.1 Scope and trends in tobacco and tobacco-related product use 
Tobacco use is the leading cause of premature death worldwide.1 The negative health outcomes 
of tobacco use have been well characterized and are numerous such as: cancers, cardiovascular 
and cerebrovascular accidents, lung diseases (i.e. chronic obstructive pulmonary disease), and 
autoimmune disorders.2 In 2005, the World Health Organization (WHO) introduced the WHO 
Framework Convention on Tobacco Control (WHO FCTC) to combat the tobacco epidemic.3 
This resolution, which is a global treaty that outlines comprehensive and multisectoral tobacco 
control strategies, plans and programs encompassing aspects related to policies of taxation, 
exposure to tobacco smoke, contents of tobacco cigarettes, packaging and labelling, health 
promotion and education, restrictions in advertising, sales to minors,  and measures promoting 
tobacco cessation.3 While in the 2018 WHO report conventional tobacco control measures have 
become more readily adopted, there is a lag in developing policies about smokeless tobacco, 
water pipe and  electronic nicotine delivery systems (ENDS).3 Globally, the WHO is reporting 
decreasing trends in conventional tobacco use in over half the countries (though 13% of the 
countries reported an increase in tobacco use), while 39% reported decreasing trends solely 
among adults.3 It is estimated that the prevalence of current tobacco smokers (past 30-day 
smokers) will continue to decrease overall among all countries stratified by World Bank income 
group (Figure 1.1); however, males in high income countries have dramatically declined from 
having the highest prevalence of current smoking to the second lowest in twenty years (Figure 
1.2).3  When examining the female prevalence of current tobacco use, while overall rates are 
decreasing, it should be noted that females in high income countries continue to have a 
significantly higher prevalence of current tobacco use compared to all other groups (Figure 1.3)3 
suggesting societal and environmental factors may be influencing their smoking behaviours. 
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Figure 1.1: Global trends in current tobacco smoking prevalence and future estimates, ages 15+ 
by countries stratified by World Bank income groups. Figure adapted from (FCTC WHO, 
2018).3 
 
 
Figure 1.2: Global trends in male current tobacco smoking prevalence and future estimates, ages 
15+ by countries stratified by World Bank income groups. Figure adapted from (FCTC WHO, 
2018).3 
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Figure 1.3: Global trends in female current tobacco smoking prevalence and future estimates, 
ages 15+ by countries stratified by World Bank income groups. Figure adapted from (FCTC 
WHO, 2018).3 
 
Canada, one of the World Bank high income countries had 45,500 deaths attributable to tobacco 
smoking in 2012.4 It is estimated that the burden of tobacco use in Canada costs upwards of 
$16.2 billion CAD per year.4 Indirect costs such as premature mortality, loss of earnings, and 
illness/comorbidities are estimated to account for approximately $9.2 billion CAD.4 While direct 
healthcare costs related to tobacco use such as hospital care, prescription drugs and physician 
visits/services amount to $6.5 billion CAD.4 Encouragingly, there has been an overall decreasing 
trend in tobacco use, though predicting the continuation of this trend may have been over-
estimated as the most recent data from 2017 shows an increase in the prevalence of current (past 
30-day) tobacco cigarette use from 13% in 2015 to 15% (4.6 million) in 2017 and a continued 
decreasing gap between male and female current smokers (Figure 1.4).5 
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Figure 1.4: Trends in the prevalence of current (past 30-day) conventional tobacco smoking 
among Canadians aged 17 years and older from 1965-2017. Figure adapted from (Reid JL et. al, 
2019).5 
 
In order to remain profitable, the tobacco industry requires continued recruitment of new 
smokers to replace those that die prematurely (Figure 1.5). It is estimated that approximately 
20% of all deaths in Canada per year are due to tobacco use6 and the expected years of potential 
life lost (YPLL) due to tobacco smoke in Canada in 2002 was estimated to be 2,151 per 100,000 
males (overall, not just smokers) and 1,302 per 100,000 females (overall, not just smokers) with 
an average age of death for males being 71.2 years and 73.4 years for females.6 
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Figure 1.5: Tobacco industry growth relies on constant recruitment to replace lost consumers 
 
Vulnerable populations are individuals or communities who due to disadvantage, inequity, social 
exclusion and social position are at increased risk of poor health.7 A study conducted in 2013 
using data about tobacco outlets from Ontario, Canada found that the majority of tobacco outlets 
were near schools and more likely to be in more deprived neighborhoods, increasing 
accessibility, normalization of the behaviour and susceptibility of youth and individuals with low 
socioeconomic status making them vulnerable to tobacco use.8 Historically, the tobacco industry 
has targeted disadvantaged groups through marketing efforts which may have led to disparities in 
smoking status based on ethnicity, sexual orientation, age and social identity.9 Documents 
revealed through litigation against the tobacco industry have shown the intentional targeting of 
youth through different methods to create a life-time consumer and to replace the tobacco 
smokers who die early.10-12 Some of the methods used to attract vulnerable populations (e.g. 
•Appealing flavourings and 
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youth, sexual minorities) include targeted advertising,11-14 appealing flavourings,13,15,16 and false 
perceptions regarding the safety of the product including its role in smoking cessation.15,17,18 
With new policies being implemented in Canada, there has been an overall decrease in 
conventional tobacco use; however, among users of non-cigarette tobacco products, 62% 
reported using a flavoured product, and among Canadian current (past 30-day) smokers, 9.3% 
reported smoking a menthol-flavoured cigarette over the past 30-days in 2017.5 There has been a 
corresponding increase in electronic cigarette (e-cigarette) use, specifically experimentation 
(ever-use) and it is especially pronounced among Canadian youth (Figure 1.6).5  
 
 
Figure 1.6: Prevalence of ever e-cigarette use and past 30-day e-cigarette use in Canada among 
adults 15 years or older 2013-2017. Figure adapted from (Reid JL et. al, 2019).5 
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To the best of our knowledge there have not been population based studies using Canadian data 
examining tobacco use among sexual minorities, who is at risk of flavoured tobacco use, what 
are the health effects of e-cigarettes and what is the relationship between e-cigarettes and 
conventional tobacco smoking. With the plethora of available nicotine delivery options in the 
market such as conventional tobacco cigarettes, flavoured tobacco cigarettes and electronic 
cigarettes, and with slowly evolving policies and restrictions, it is imperative to assess trends and 
determinants of their use. This is important as Canadian smoking related behaviours are 
continually evolving, with different sub-populations using different products (i.e. youth and 
young adults vs. older adults, by sex, and sexual orientation). Flavoured tobacco cigarettes were 
heavily marketed towards susceptible youth and more recently, e-cigarettes which are an 
electronic nicotine delivery system (ENDS) which has not been strongly regulated in Canada and 
thus may pose significant, previously uncharacterized/unknown health effects. 
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1.1.2 Flavoured tobacco smoking in Canada 
Flavoured tobacco products (menthol cigarettes, flavoured little cigar or cigarillo, flavoured 
cigar, flavoured tobacco in water pipe [hookah]) come in flavours appealing to youth including 
vanilla, chocolate, bubble-gum, watermelon, cherry and strawberry.19 They are packaged in 
attractive colours targeting youth and carried no health warnings.19 Flavoured tobacco products 
are associated with less throat and upper respiratory tract irritation, making it easier to initiate 
tobacco use and to continue to smoke, exposing youth to the long term effects of nicotine and 
cigarettes.19 This modality of tobacco exposure puts youth at risk to become addicted to nicotine 
and establish life-long patterns persisting into adulthood.10 
Similar to current strategies being employed with e-cigarettes, flavoured tobacco products are 
falsely advertised as potential smoking cessation aids that led to harm reduction by the tobacco 
industry.18 Moreover, similar to e-cigarettes today, most younger flavoured tobacco users believe 
them to be less harmful than regular cigarettes20-22 with one third of US adults sampled in a study 
believing there were minimal harmful effects due to using flavoured tobacco products.23 These 
inaccurate beliefs are based on effective and misleading marketing campaigns created by the 
tobacco industry24 and oppose the increasing evidence detailing a plethora of negative health 
effects attributed to the use of flavoured tobacco.25-27 
In 2010, due to the increased use of flavoured tobacco among Canadian youth,28 and health 
concerns29,30, federal legislation (Bill C-32)31 was introduced to ban the sale of flavoured tobacco 
products (cigarettes, little cigars, cigarillos, and blunt wraps) weighing less than 1.4 g which 
contain flavouring agents excluding menthol which was argued to not be attractive to youth.31 
However, despite the introduction of legislation, over half of the tobacco using Canadian 
students reported using flavoured tobacco in 2011.29 Contrary to suggestions that youth did not 
use menthol cigarettes, 32% of past 30-day tobacco users in Canadian high schools reported 
using menthol cigarettes in 2011.29 Eventually, in 2018, amendments to the tobacco and vaping 
products act banned menthol and clove additives to all tobacco products.32 Results of this policy 
change remain to be seen, but it could lead to a shift in Canadian smoking related behaviours 
from flavoured tobacco cigarettes to flavoured e-cigarettes, especially among youth. 
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1.1.3 Tobacco cigarette smoking among Canadian sexual minorities 
Conventional tobacco cigarette use remains a significant public health concern among Canadians 
as the majority of Canadians who use nicotine products use conventional tobacco cigarettes. 
Therefore, the effects of policy and investigating smoking related behaviours among vulnerable 
subgroups is a necessity. Although extensive research on tobacco smoking behaviours and its 
prevalence already exists, there is limited research on the tobacco smoking behaviours of 
Canadian sexual minorities (lesbian, gay and bisexual). It has been estimated that 3.9% of 
Canadians are lesbian, gay or bisexual (LGB) according to the 2012 Canadian Community 
Health Survey – Mental Health (CCHS-MH).33 Compounding the relationship between the LGB 
community (a highly vulnerable population) with tobacco cigarette use is that they have been 
historically selectively targeted and recruited by the tobacco industry34-37 and report significantly 
higher risk for substance use including smoking, when compared to heterosexuals.38-43  
Furthermore, sexual orientation has been reported to be independently related to many adverse 
health behaviours such as smoking, due to the unique risk factors faced by individuals who are 
identify as members of a sexual minority. The disparities reported in LGB smoking rates may be 
partially attributed to issues of disclosure, stigma and internalized homophobia.44 Studies have 
suggested that sexual minorities experience disproportionately increased stress, depression, 
victimization, socialization in smoky areas, aggressive tobacco marketing, and substance 
abuse.44-46 Moreover, minority stress theory posits that LGB individuals may use maladaptive 
coping behaviors, such as smoking because of their lived experience, facing chronic, social and 
structural stressors, which may partially help explain the higher rates of smoking seen in this 
unique population.47-49 To date, the majority of studies investigating conventional tobacco 
smoking among Canadian sexual minorities have found increased rates of smoking, but these 
studies were limited by factors such as small sample sizes, limitations by biological sex (i.e. 
women only), evaluation of single groups (i.e. high school students, men who have sex with 
men) and geographical region, and to date there has not been a national study.38-41 
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1.1.4 Electronic cigarette use in Canada 
E-cigarettes are a type of electronic nicotine delivery system (ENDS) containing batteries and 
emit vapour, however, no combustion takes place.50 E-cigarettes contain a lithium battery, have a 
tank that is filled with e-cigarette liquid, an atomizer to heat the liquid and a mouthpiece for 
suction (Figure 1.7).51 
 
Figure 1.7: Schematic representation of an e-cigarette.51 “Reprinted from Toxicology, Vol 365, 
Kaisar MA, Prasad S, Liles T, Cucullo L. A decade of e-cigarettes: Limited research & 
unresolved safety concerns, Page 68, Copyright (2016), with permission from Elsevier” 
 
There are different levels of nicotine (from no nicotine to higher levels), and flavourings 
available which may appeal to youth and young adults similar to how flavoured tobacco was 
marketed.52,53 Furthermore, there is evidence suggesting adult e-cigarette users are more likely to 
use tobacco flavour while youth were more susceptible to multiple flavour categories, the most 
common being fruit and candy54 suggesting age based flavour preferences. This is unsurprising 
as flavoured tobacco is more attractive to youth rather than older adults;55 and the longitudinal 
Population Assessment of Tobacco and Health Study in the USA found that youth who self-
reported experimenting with tobacco products (cigarettes, flavoured tobacco, e-cigarettes, any 
cigar, hookah, smokeless tobacco, snus pouch, pipe, bidi, kretek, and dissolvable tobacco 
product use) consistently initiated with flavoured products.56  
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E-Cigarettes were patented globally by a Chinese pharmacist in 2007 and has since been adopted 
throughout the world.51 The high rate of adoption globally can be attributed to several factors 
related to perceptions in safety, facilitating smoking cessation, low potential for harm, low price, 
lax policies, social trends and peer pressure.51,57 E-Cigarettes are widely promoted on social 
media and misinformed beliefs and perceived knowledge are influencing e-cigarette use. A 
recent study concluded there are both negative and positive connotations regarding e-cigarette 
use on social media however, there were overall more positive sentiments,58 with another study 
finding e-cigarette exposure through social media was associated with use through positive 
outcome expectancies in smoking experiences and sensory experience.59 As social media is 
largely unregulated it is important for public health professionals to start disseminating evidence-
based/science-supported information to impressionable youth on these platforms. 
When examining the growth of e-cigarettes, a recent study from the United States concluded that 
nicotine containing e-cigarette use has nearly doubled among high school seniors from 11% to 
21% over one year (2017-2018).60 While in Canada, trends in e-cigarette use among youth have 
not been as pronounced, with 10% of Canadian students in grades 7-12 reporting past 30-day e-
cigarette use (2016-2017), however, this is still an alarming trend as the rate has increased from 
6.5% (2014-2015) according to the 2016-2017 Canadian Student Tobacco, Alcohol and Drugs 
Survey (CSTADS).61 Interestingly, there has been substantial provincial variability in past-30 
day e-cigarette use with students in Ontario reporting the lowest rate (6.6% in 2016-2017)62 
while Newfoundland and Labrador reported the highest rate of 22.4%,63 higher than rates 
reported in the United States among high school seniors. When examining the overall rates of e-
cigarette use in Canada, 1% (292,000) reported daily use, 2.9% (863,000) reported past 30-day 
use and 15.4% (4,600,000) reported being ever users (individuals who ever used an e-cigarette, 
even a few puffs) (Figure 1.6)5 with males having a higher prevalence of ever use and past 30-
day use consistently compared to females, and while the gap by sex has widened from 2013 and 
2017, ever use of e-cigarettes continues to grow irrespective of sex (Figure 1.8).5 
  
 
12 
 
 
Figure 1.8: Prevalence of ever and past 30-day e-cigarette use among Canadian adults 15 years 
or older by sex, 2013-2017. Figure adapted from (Reid JL et. al, 2019).5 
 
Studies examining the harm potential of e-cigarettes have found that they may actually be more 
addictive than conventional tobacco cigarettes,64 and might be independently associated with a 
wide array of negative health consequences such as poor oral health,65,66 asthma,67 initiation of 
substance use and effects on brain maturation,68 fetal development,69,70 and chronic obstructive 
pulmonary disease (COPD).71-74 In addition, there have been recently reported unexpected deaths 
linked to E-cigarette or Vaping-product associated lung injury (EVALI)75,76 and injuries due to 
malfunction and or explosion of the device.77,78 
1.1.4.1 Electronic cigarettes and chronic obstructive pulmonary disease 
Chronic obstructive pulmonary disease has a global prevalence of 65 million, and it is predicted 
to become the third leading cause of death worldwide by 2030.79 Tobacco smoke has been 
identified as the dominant cause of COPD.2 Thus, it is imperative to examine the effects of new 
nicotine delivery devices such as e-cigarettes in order to assess and characterize potential 
negative health outcomes associated with their use, such as COPD. A recent study has 
characterized the development of COPD like effects in mice inhaling nicotine containing e-
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cigarette vapour by affecting cytokine expression, hyper-reactivity of the airway, and lung tissue 
destruction.71 While an in-vitro study, examining the effect of e-cigarette vapour condensate on 
human alveolar macrophages concluded that there was evidence of up-regulation of oxidative 
stress related proteins such as MMP-9, reactive oxygen species, inflammatory cytokines and 
chemokines along with decreased bacterial clearance which enhances susceptibility to COPD.72 
Moreover, another in vitro study concluded that e-cigarettes had a lower impact on gene 
expression compared to conventional tobacco however an effect greater than standard air was 
seen in changes to genes mapping metabolic/biosynthetic processes, cell apoptosis, hypoxia and 
extracellular membrane pathways.73 In addition, there is strong evidence indicating that the 
exposure to e-cigarette vapours impact airway inflammation, potentially via altering gene 
transcription and increase susceptibility to airway infection, the development of COPD, or even 
potentially lung cancer.72-74 Conducting a population-based study using Canadian data to 
examine if an association exists between e-cigarette use and COPD using a large sample size, 
would add to the existing body of literature. 
1.1.4.2 Electronic cigarettes and tobacco initiation 
In Canada, two recently published longitudinal studies suggest that e-cigarettes are associated 
with conventional tobacco initiation.80,81 This trend has been seen in other countries including the 
USA, Germany, UK and China (Taiwan). The growing evidence suggests e-cigarettes are 
potentially expanding the population of future conventional smokers as e-cigarettes are 
particularly attractive and addictive for never tobacco smokers (Figure 1.9).81,82  
 
Figure 1.9: Paradigm shift in recruiting conventional tobacco users with potentially delayed 
effects seen at the population level 
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Based on these findings, it is entirely possible that e-cigarettes are a tool being used to 
circumvent policies enacted to combat the tobacco epidemic3 and without appropriate safeguards 
in place (i.e. policy), there could be delayed long term adverse effects due to e-cigarette use 
unraveling the positive work done through health promotion, education and policy initiatives.  
Insofar as current evidence, a recent systematic review and meta-analyses supports this 
hypothesis, finding that baseline ever e-cigarette users had a 30.4% pooled probability of tobacco 
initiation, while the probability of baseline never e-cigarette users initiating tobacco use was only 
7.9% (an almost 8 fold increase), however there were limitations in the studies pooled.83 In 
contrast, a 2019 study conducted in the US reported an association between the decrease in youth 
tobacco use with increased e-cigarette use but found  no significant relationship between e-
cigarette use and tobacco initiation; it is important to note that this study focused on youth and 
had a relatively short follow-up period potentially limiting the results.84 As there is conflicting 
evidence in the literature with respect to the role of e-cigarettes in the conventional tobacco 
initiation, further examination is required with factors such as length of follow up, age, sex and 
magnitude of e-cigarette use (past 30-day/ever user/never user; acute vs. chronic user) needing to 
be standardized and accounted for. 
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1.2 Research Questions 
This thesis aims to examine Canadian smoking related behaviours and to determine what are 
their prevalence, characteristics, determinants and health outcomes at the overall population level 
and stratified by vulnerable populations (LGB, high school students). 
1.3 Objectives 
To answer our research question, this thesis consists in four objectives: 
1. To assess determinants of flavoured tobacco use among Canadian youth by analyzing a 
national generalizable survey (Chapter 3). This manuscript has been peer-reviewed and 
published. 
2. To assess and determine the prevalence and determinants associated with tobacco 
cigarette use among the Canadian LGB community using national, generalizable data 
(Chapter 4). This article has been submitted for publication and currently under review. 
3. To assess the prevalence of COPD among past 30-day e-cigarette users and to quantify 
the association between e-cigarette use and COPD as well as between dual use of tobacco 
and e-cigarettes, and COPD using Canadian data (Chapter 5). 
4. To determine and quantify whether the use of e-cigarettes leads to conventional tobacco 
initiation among never users, a systematic review and meta-analysis (Chapter 6). 
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1.4 Relevance 
In 2015, the Canadian Tobacco, Alcohol and Drugs Survey (CTADS) found the prevalence of 
current tobacco use (past 30-day) was the lowest ever recorded for Canadians (13%),85 
suggesting that health promotion, policy and anti-tobacco campaigns were delivering promising 
results. However, the 2017 CTADS found an increase in the prevalence of current (past 30-day) 
tobacco use of approximately 15%,5 suggesting either a plateau in the efficacy of current efforts 
in curbing tobacco use or an actual unexpected increase due to novel trends/factors previously 
unaccounted for. An actual increase will lead to increased burden on the Canadian healthcare 
system and the population as a whole. As the Canadian population is steadily aging, significant 
increases in morbidity and mortality could have unforeseen impacts on the healthcare system. A 
recent review examining pro-tobacco and anti-tobacco campaigns aimed at vulnerable 
populations identified significant gaps in the literature pertaining to tobacco use among the 
lesbian, gay, bisexual and transgender (LGBT) population,86 suggesting a need for additional 
studies. This is even further compounded in Canada as there is a major dearth in studies 
examining tobacco use patterns among the LGB community partially attributed to the small size 
of the community, requiring large sample sizes to make meaningful conclusions.87 One of the 
objectives of this thesis is to assess trends and determinants of tobacco use among the Canadian 
LGB community, and to address the challenge of the sample size of the LGB population, several 
cycles of the Canadian Community Health Survey (CCHS) were merged and analyzed as 
indicated. 
Although most of the flavoured tobacco has been banned in Canada since 2018, there are many 
lessons and relevant findings still applicable today. At the time of the study (Chapter 3), 
flavoured tobacco was not banned, and the use was still growing. Furthermore, it appears 
marketing strategies for flavoured tobacco have shifted to current e-cigarette marketing 
techniques. Flavoured tobacco was marketed as safe to use, with a low harm potential, less 
irritative to the throat and airway, with attractive flavours which appeal to youth, and as a 
potential tobacco cessation method.18, 20-22  The  flavoured tobacco products still available today 
in Canada including Hookah (Water Pipe) need to be followed. This study (Chapter 3) shed light 
on the prevalence and determinants of flavoured tobacco use among Canadian youth and results 
can be applied to e-cigarette use as well as to other forms of flavoured tobacco still available.  
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The Canadian Public Health Association (CPHA) released a statement in 2018 that stated the 
long term health effects of e-cigarettes are unknown, requiring further research and there is 
conflicting evidence on vaping devices acting as gateway devices to future conventional tobacco 
initiation.88 There have been a significant amount of studies published since 2018 on e-cigarettes 
as a tobacco initiation devices warranting an updated systematic review and meta-analysis. This 
thesis aims to provide additional evidence from a Canadian perspective into potential harms of e-
cigarettes, focusing on COPD and dual use of conventional tobacco products with e-cigarettes. 
Our results will help assess whether e-cigarettes are potentially harmful by assessing the 
association between COPD and e-cigarettes and if they may serve as tobacco initiation devices. 
By applying the multiple tobacco product use framework,89 examining the relationship between 
Canadian smoking related behaviours (conventional tobacco, flavoured tobacco and e-cigarettes) 
and their determinants, prevalence in vulnerable populations and potential harms will be studied 
while accounting for person-level factors, situational factors, and product level factors.  
The first two objectives focus on the prevalence, trends and determinants of tobacco use among 
vulnerable Canadian populations: Canadian high school students in grades 10-12 and the LGB 
population. The latter two objectives will examine e-cigarettes; specifically, whether their use is 
associated with COPD using a large dataset (data from Ontario, British Columbia, Nova Scotia 
and Northwest Territories) and whether they can cause tobacco initiation leading to unforeseen 
future adverse effects (Figure 1.10). 
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Figure 1.10: Overview of the objectives of this thesis 
This thesis adds to tobacco-related research in Canada by, by addressing several gaps in current 
knowledge, provides new evidence, and results have been presented at different conferences in 
both oral and poster presentations. Four manuscripts have been prepared as follows. 
1. To address the prevalence and determinants of flavoured tobacco use among Canadian 
youth, a potential conventional tobacco initiation gateway (Chapter 3). 
2. To examine determinants and the prevalence of tobacco smoking among the Canadian 
LGB community using a population-based dataset (Chapter 4). 
3. To examine if e-cigarette use is independently associated with COPD using Canadian 
data (Chapter 5). 
4. To provide additional evidence to address the lack of consensus regarding the role of e-
cigarettes as tobacco initiation devices by collating the latest results from ongoing 
longitudinal studies and incorporating them with previous data (Chapter 6). 
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Overall, this thesis provides up to date, new evidence about Canadian smoking related 
behaviours to better inform public health practitioners, patients, family members, and policy 
makers thus positively impacting health, awareness and tobacco control and prevention efforts at 
the individual and population level. 
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2. CHAPTER 2: METHODS 
2.1 Multiple tobacco product use theoretical framework 
The multiple tobacco product use theoretical framework (MTPTF) draws from health behaviour 
theories, marketing and behavioural economic literatures.1 When assessing determinants 
(Chapter 3, Chapter 4, Chapter 5), choosing what factor(s) to include in multivariable analysis 
requires statistical, temporal, social and biological considerations to be taken into account.2 A 
conceptual framework allows the understanding of the hierarchical relationships between the 
variables, what their relationship is and help to organize potential research ideas but do not 
explain outcomes.2,3 Theories are developed based on conceptual frameworks which help in 
elaborating hypotheses, assumptions and direction, after which models are developed to test the 
assumptions about the variables and outcomes under study.3 Incorporating a conceptual 
framework, and theory allows for a logical model to be developed facilitating in identifying and 
testing relevant research questions. The variables tested in this paper (Chapter 3-5) were based 
on the MTPTF, and using this conceptual framework allowing us to understand the relationship 
between variables, followed by the development of our theory gives us a sound foundation and 
improves our final effect estimates.2 
The MTPTF framework improves the understanding of the influence of one nicotine related 
product on others (i.e. e-cigarettes on conventional tobacco, flavoured tobacco on conventional 
tobacco etc.), understanding the proximal and distal determinants of specific smoking related 
behaviours (i.e. e-cigarettes vs. conventional tobacco vs. flavoured tobacco), and how they 
impact health (i.e. COPD).1 Furthermore, this theoretical framework accounts for individual 
factors, the influence of the product on the individual and situational factors, and product 
characteristics, and how they impact smoking related behaviours (Figure 2.1).1  
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Therefore, for the purposes of this thesis, the MTPTF is an ideal framework to help identifies 
factors in a hierarchical manner that need to be assessed when examining the association 
between smoking related behaviours and negative health outcomes (COPD, tobacco initiation, 
flavoured tobacco use and standard tobacco use), accounts for vulnerable populations through 
“person x product” and person-level factors (i.e. LGB community, impressionable youth) and 
helps examine the interplay between choices made between different smoking related behaviours 
(i.e. dual e-cigarette and tobacco use). For the purposes of this thesis we will incorporate person-
level, situational and product factors, examine the dynamic complementarity between e-
cigarettes and conventional tobacco, examine the effects on health outcomes and addictive 
potential. 
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Figure 2.1: The multiple tobacco product use conceptual framework (Pacek LR, et al. 2019).1 Figure modified with permission from 
Oxford University Press. Hx denotes history 
Products A-F are different tobacco products such as conventional tobacco cigarettes, flavoured tobacco cigarettes and e-cigarettes
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2.2 Study design 
This thesis uses two types of study design, cross-sectional (Chapter 3, 4, 5), and a systematic 
review and meta-analysis (Chapter 6). The cross-sectional studies enable the analysis of large 
population cohorts and sub-populations in an comprehensive and timely manner.4 They are of 
value for the purpose of this thesis because Canadian smoking related behaviours continue to 
develop and evolve, and otherwise it will take decades to assess the long-term consequences of 
newer tobacco/nicotine products (i.e. e-cigarettes). As such, cross-sectional studies are quick, 
usually covering one time point or a short time period. Results can estimate the prevalence of a 
given outcome (i.e. smoking behaviour), allowing for the assessment of current patterns (i.e. 
changes in tobacco use among Canadians).5 Due to the recent emergence of alternative tobacco 
products (i.e. flavoured tobacco, e-cigarettes), cross-sectional studies are a valuable tool for 
public health planning, allowing for a early understanding of the etiology of the specific 
behaviour, and for hypothesis generation.5 There are limitations when using cross-sectional 
studies; we cannot infer causation due to not having a  temporality component, only the 
association between outcome and exposure, data is representative of a specific period of time and 
the potential for bias when assessing mortality as risk factors that result in death are under-
represented in the diseased, especially in cases of chronic disease states.5 
Systematic review and meta-analysis are useful to provide pooled information to address the 
current gaps in the knowledge.6 For the purpose of this thesis, we will use a systematic review 
and meta-analysis to address an area with a lack of consensus in the literature, whether existing 
evidence supports the hypothesis that e-cigarettes are tobacco initiation devices. A systematic 
review uses explicit methodology to minimize bias when attempting to collect evidence based on 
pre-specified eligibility criteria.6 There are four components to a proper systematic review: a. 
clear objectives with reproducible methodology; b. systematic search to include studies meeting 
the eligibility criteria; c. assessing the validity of the included studies and d. a systematic 
presentation of the characteristics, findings and synthesis of the included studies.6,7  The meta-
analysis allows the combination of data from different studies to provide a better estimate of the 
relationship between the intervention/exposure (i.e. e-cigarette use) and outcome (i.e. tobacco 
initiation).6 Due to the recency of e-cigarette use, there are few longitudinal studies currently 
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available assessing their effect on conventional tobacco initiation and there are some conflicting 
findings. Using this approach allows us to account for disparities and studies heterogeneity in the 
literature, and to minimize bias by using a specific, reproducible, and rigorous methodology.7 
2.3 Data sources 
The Youth Smoking Survey (YSS) is a Canadian national cross-sectional, stratified design, 
school-based survey. The 2012-2013 cycle was used for analyzing the prevalence of flavoured 
tobacco use and assessing the risk profile of Canadian youth in Chapter 3. Data was collected 
from students in grades 7-12 across 450 schools in Canada. Schools from the province of 
Manitoba and the Northwest, Nunavut and Yukon territories and students living in institutions or 
on First Nations reserves did not participate in the survey.8 Stratification was based on health 
region smoking rates, the participating school’s postal code and the population size of major 
metropolitan areas.8 The survey’s design and sample weight allow for population-based 
estimates.9  
To examine the association between sexual orientation and smoking preferences among LGB 
Canadians (Chapter 4), the Canadian Community Health Survey (CCHS) cycles from 2009-2014 
were used. The CCHS is an annual, nationally representative, population-based survey, which 
aims to assess the health status, health service usage and determinants of health among people 
living in Canada.10 Data analysis was conducted in the Saskatchewan Research Data Centre 
(SKY-RDC), and the CCHS master files from survey cycles (2009-2014) were merged and 
analyzed using a pooled approach to maximize the sample size due to the low prevalence of 
sexual minority respondents. Merging the cycles and scaling of the weights were conducted 
according to established guidelines.11 Due to privacy concerns, the RDC only released weighted 
results to be generalizable to the Canadian population aged 18-59 years old. 
The CCHS 2015/2016 cycle (same survey design as Chapter 4 but different cycle) was used to 
assess the prevalence of COPD among e-cigarette users in Ontario, British Columbia, Nova 
Scotia and the Northwest Territories, to determine whether an association between e-cigarette 
use and chronic obstructive pulmonary disease (COPD) exists and what is the effect of dual use 
(e-cigarette and conventional tobacco) on the association with COPD in Chapter 5. The final 
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sample size in this analysis was 37.754 individuals aged 35 years or older, with the prevalence of 
COPD being 5.35% and the prevalence of past 30-day e-cigarette use being 2.31%. 
For the systematic review and meta-analysis examining whether e-cigarettes are tobacco 
initiation devices (Chapter 6), the following databases were searched: PubMed, MEDLINE: 
Ovid MEDLINE, Public Health Database, Scopus and Cochrane Library databases. Longitudinal 
studies published since 2010 were included. The PRISMA-P guidelines were followed in the 
conception, methodology and reporting of this systematic review and meta-analysis.6  
2.4 Sex and gender in health research 
In chapters 3-5, sex and gender, important health determinants are incorporated in our analysis 
where applicable. By including sex and gender in research, their health impacts can be assessed, 
and innovative evidence can be used to improve the health of everyone.12 Sex and gender are 
often overlooked but important factors to improve the external validity of research in order to 
make the results generalizable to the entire population.13 Failure to account for these factors in 
research could potentially lead to greater health inequities.14 
The Canadian Institutes of Health Research (CIHR) defines sex as “a set of biological attributes 
in humans and animals. It is primarily associated with physical and physiological features 
including chromosomes, gene expression, hormone levels and function, and reproductive/sexual 
anatomy. Sex is usually categorized as female or male but there is variation in the biological 
attributes that comprise sex and how those attributes are expressed.”15 Gender on the other hand 
is defined as the “socially constructed roles, behaviours, expressions and identities of girls, 
women, boys, men, and gender diverse people. It influences how people perceive themselves and 
each other, how they act and interact, and the distribution of power and resources in society. 
Gender is usually conceptualized as a binary (girl/woman and boy/man) yet there is considerable 
diversity in how individuals and groups understand, experience, and express it.”15  
In chapters 3 and 5 we used biological sex to assess sex-based differences in the determinants 
flavoured tobacco use (Chapter 3) and to assess the association between e-cigarette use and 
chronic obstructive pulmonary disease (Chapter 5). In Chapter 4 we examine whether sexual 
orientation is independently associated with conventional tobacco smoking. Here, we examine 
biological sex and sexual orientation. While sexual orientation is distinct from gender, there is an 
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intersection between the two among communities who do not identify as heterosexual or cis-
gender.16 For the purpose of the study in chapter 4, we used the definitions for sexual orientation 
as stated by the CCHS; heterosexuals are individuals that have sexual relations with people of 
the opposite sex, gay are biological males that have sexual relations with biological males, 
lesbian are biological females that have sexual relations with biological females and bisexual are 
individuals that have sexual relations with both sexes.17 By examining both biological sex and 
sexual orientation and disaggregating the data by biological sex we were able to better account 
for these health determinants and improve the external validity of our results. 
2.5 Regression analysis 
2.5.1 Logistic regression 
Logistic regression is a versatile regression technique that can be used to measure the association 
between an exposure and outcome, predict outcomes and control for confounding.18-20 Logistic 
regression can be utilized for binary outcome events (i.e. flavoured tobacco use, Chapter 3; and 
past 30-day e-cigarette use, Chapter 5) with either continuous, ordinal or categorical independent 
variables.18 By incorporating multiple variables we get a better estimate of the pure effect of the 
independent variable of interest when adjusting for the other independent variables.18 
Assumptions for logistic regression include the independence of observations, linear relationship 
between logit for continuous variables and the logit of the outcome variable, no multicollinearity 
between the independent variables and no highly influential outliers.18 
Variable selection in this thesis were based on variables included in the multiple tobacco product 
use framework (Figure 2.1), clinical considerations, and literature review. To build our models in 
Chapters 3,4,5 we used the purposeful selection methodology.18-20 The purpose of this 
methodology is to develop the most parsimonious model that best represents the outcomes of the 
data.19 After assessing descriptive statistics between the outcome and independent variables, 
univariate analysis was conducted in order to determine the crude (unadjusted) association 
between the outcome variable and each independent variable using a p-value of 0.25.19 Variables 
found statistically significant in univariate analysis were kept for multivariable model building. 
When building the multivariable models, we used backwards elimination strategy where all 
significant independent variables were initially included. Variables that were not statistically or 
clinically significant (p-value > 0.05) were removed one at a time. When a variable was 
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removed, the regression coefficient (β) of the primary independent variable (i.e. e-cigarette use in 
chapter 5) was compared in the initial model and the new model without the variable that was 
removed. If the difference in the regression coefficient was greater than 20%, the variable 
removed was providing an important adjustment and returned and kept in the model.19 Once 
model fit is complete, multicollinearity is assessed via the variance inflation factor (VIF) and 
tolerance (TOL) values. If VIF ≥ 2.5 we assumed there is evidence of multicollinearity.21 All 
two-way interactions were assessed between the primary independent variable and other 
independent variables. In Chapter 5, we have evidence of effect modification by sex which was 
included in Models 2 & 3. Once the final model is complete, model fit was assessed using the 
Hosmer Lemeshow Goodness of Fit test where a non-significant value (p-value > 0.05) suggests 
the model is a good fit of the data.19 In cases where we had to select between statistically similar 
models, we used the simpler, more parsimonious model unless relevant practical/clinical 
considerations were lost by dropping variable(s) of interest. Odds ratios were reported, which 
give the strength of association between the independent variable and the outcome after 
controlling for the other independent variables.18 
2.5.2 Multinomial logistic regression 
Multinomial logistic regression is similar to binary logistic regression however the outcome 
variable has greater than two levels.22,23 In Chapter 4 we use a multinomial logistic regression 
with conventional tobacco use status (nominal categories: current user, former user and never 
user) being the levels of the outcome variable. Model building followed the same steps as with 
binary logistic regression analysis however the deviance was used as the Goodness of Fit test 
with a deviance > 0.05 indicating the model adequately fits the data.22 The outcome will be an 
odds ratio but with each level compared to the reference group. For example, in Chapter 4 we 
can see the odds ratio were interpreted as current smoker vs. never smoker and former smoker vs. 
never smoker.  
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2.6 Systematic Review and Meta-Analysis 
The systematic review and meta-analysis conducted in Chapter 6 follows PRISMA-P 
guidelines.6 The population of interest are humans who are never tobacco smokers at baseline. 
The intervention of interest is e-cigarette use, comparators are never e-cigarette users and the 
outcome of interest is tobacco initiation and current conventional tobacco use. Methods are 
discussed in detail in Chapter 6. The risk of bias is assessed using a modified Newcastle Ottawa 
Scale for cohort studies.24 The meta-analysis was conducted using Comprehensive Meta-
Analysis version 3 (Biostat Inc., Englewood, NJ, USA). 
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3. CHAPTER 3: PREVALENCE AND CHARACTERISTICS OF 
FLAVOURED TOBACCO USE AMONG STUDENTS IN GRADES 10 
THROUGH 12: A NATIONAL CROSS-SECTIONAL STUDY IN 
CANADA, 2012-20131 
Introduction: Tobacco use is the leading cause of preventable death in Canada and worldwide. 
Despite decreases in the prevalence of smoking in Canada, increases in flavoured tobacco use by 
youth poses a serious public health concern. This study examined the prevalence and 
characteristics of flavoured tobacco use among a national sample of students (grades 10-12). 
Methods: This study used a cross-sectional design on a nationally generalizable, school-based, 
Youth Smoking Survey (YSS), 2012–2013. It incorporated data from a representative sample of 
19,979 students in grades 10–12 from across Canada. Univariate and multivariate logistic 
regression models were used to examine differences in flavoured tobacco use by demographic 
and social characteristics. 
Results: This study found that 14.8% of the participating students used flavoured tobacco in the 
past 30-days. Results of the logistic regression analysis show that flavoured tobacco use was 
significantly higher among male students [(aOR = 1.63; 95% CI = 1.36–1.95)], who had at least 
one friend or sibling who smoke [(aOR = 2.20; CI = 1.62 to 2.99) and (aOR = 1.51; CI = 1.22 to 
1.88), respectively] and who received greater than $20/week in personal spending money 
[(aOR = 1.76; CI = 1.26 to 2.45)]. 
Conclusions: The results of our study indicate that flavoured tobacco use is a public health 
concern and has a strong appeal among youth in Canada. This is a particularly troubling finding, 
especially in light of the fact that there is a national ban on certain flavoured tobacco products. 
To be effective, strategies specifically tailored for youth using flavoured tobacco would require 
appropriate educational/prevention initiatives, more comprehensive legislation and better 
regulatory mechanisms. 
Keywords: Flavoured tobacco, Adolescents, Canada 
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3.1 Introduction 
Tobacco use is the leading cause of preventable death in Canada and the world.1 It has been 
associated with a range of medical conditions known to cause significant morbidity and 
mortality.1 Current global estimates of the mortality from tobacco stand at 6 million deaths 
annually.2 Since the 1990’s, intense public health efforts have concentrated in reducing the 
burden of disease resulting from tobacco. These actions have effectively contributed to a steady 
decline of smoking rates over time.3,4 In Canada, it is estimated that the prevalence of smoking is 
currently at its lowest point in nearly two decades4 and the average number of cigarettes smoked 
daily has decreased by more than 2 cigarettes since 1999.3 
These encouraging trends are threatened by the documented growing appeal of flavoured tobacco 
(menthol cigarettes, flavoured little cigar or cigarillo, flavoured cigar, flavoured tobacco in water 
pipe [hookah]) among youth.5,6 It has been reported that approximately 2 of every 5 current 
youth smokers (approximately 126,000 young Canadians), use flavoured tobacco.7 These 
tobacco products come in flavours that appeal to youth including vanilla, chocolate, bubble-gum, 
watermelon, cherry, and strawberry. They are packaged in enticing colours aimed at youth and 
carry no health warnings. They are associated with less throat and upper respiratory tract 
irritation, which makes it easier to start and continue to smoke them and exposes youth to the 
long-term effects of nicotine.8 This puts youth at risk to become addicted and establish use 
patterns/addiction that persist into adulthood, making them life-long tobacco consumers.9 
Flavoured tobacco products have been falsely advertised as possible aids for smoking cessation 
and harm reduction by the tobacco industry.10 Thus, it is not surprising to find that most young 
flavoured tobacco users believe them to be less harmful than regular cigarettes.11-13 Similarly, 
one third of adults sampled in a US study believed the harmful effects of flavoured tobacco to be 
minimal.14 These erroneous beliefs are fundamentally premised on an effective but misleading 
marketing campaign by the tobacco industry15 and stand in stark contrast to the mounting 
evidence in the literature that details a number of deleterious effects attributed to the use of 
flavoured tobacco.16-18 
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In Canada, concerns over the health effects of flavoured tobacco products5,19 along with their rise 
in popularity among youth20 led the Canadian government to implement Bill C-32 in July 2010.21 
Bill C-32 prohibits the sale of cigarettes, little cigars and cigarillos, and blunt wraps that weigh 
less than 1.4 g and contain flavouring agents (excluding menthol). However, Bill C-32 does not 
cover all tobacco products and many manufacturers simply increased the weight of their products 
to more than 1.4 g to circumvent the law. Thus, despite the national ban, it has been reported that 
more than half of high school students in Canada who smoke, use flavoured tobacco.6 
Flavoured tobacco use among Canadian youth is the result of a set of complex and dynamic 
interactions between youth and their social environment. However, the interactions between their 
demographic (sex, grade and ethnicity) and social characteristics (friends, siblings, 
parents/guardian who are smokers and weekly personal spending money) have not been 
sufficiently studied. The present study aims to use a large, nationally representative sample in 
order to identify the prevalence and characteristics associated with the use of flavoured tobacco 
among Canadian students in grades 10 through 12. 
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3.2 Methods 
3.2.1 Study design 
This study used a cross-sectional, stratified design on a nationally generalizable, school-based 
Youth Smoking Survey (YSS) in 2012–2013. Stratification was based on the health region 
smoking rates (as determined by the Canadian Community Health Survey data), the participating 
school’s postal code and the population size of major metropolitan areas.22 The survey design 
and sample weights allow for population-based estimates and have been explained in detail 
elsewhere.23 
3.2.2 Participants 
The 2012–2013 YSS involved a total of 38,667 student participants from grades 7–12 across 450 
schools in Canada. Schools from the province of Manitoba and the Northwest, Nunavut and 
Yukon territories as well as students living in institutions or on First Nations reserves did not 
participate in the survey. Research has shown that students in lower grades (7–9) differ 
significantly from students in higher grades (10–12) with regard to their behaviours and a variety 
of measures relating to tobacco use.24 Our study focused on students in grades 10–12 
(n = 19,979). 
3.2.3 Variables explored 
Outcome variable 
The outcome variable was current flavoured tobacco use (past 30-day use). The outcome variable 
was derived from a question in the YSS asking: “In the last 30-days, did you use any of the 
following flavoured tobacco products?” Responses included: “menthol cigarettes (Yes/No), 
flavoured little cigar or cigarillo (Yes/No), flavoured cigar (Yes/No), flavoured tobacco in water 
pipe (hookah) (Yes/No).” Students who answered yes to any of these four questions were 
classified as being current flavoured tobacco users. 
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Independent variables 
The independent variables of interest included the respondent’s demographic (sex = male/female; 
ethnicity = White, Black, Asian, Aboriginal, Hispanic; grade = 10–12) and social characteristics 
(how many of the respondent’s friends, siblings and parents/guardians are smokers = 0, 1, 2, 3 or 
more; weekly personal spending money = $0 to > $100). 
3.2.4 Data analysis 
The survey was weighted by the data provider in order to adjust for differential response rates 
across groups and to allow for generalization of the findings to the Canadian student 
population.22 Our study used descriptive analysis to summarize the basic features of the data, 
looking at frequencies and distributions of the outcome and independent variables of interest. 
Univariate analysis was conducted to determine the crude association between each of the 
independent variables (sex, grade, ethnicity, number of friends, siblings, and parents/guardians 
who smoke and weekly personal spending money) and the outcome variable of interest 
(flavoured tobacco use). Logistic regression modelling was carried out using the PROC 
SURVEYLOGISTIC command to examine the relationship between flavoured tobacco use and 
the independent variables of interest. 
Assumptions of logistic regression were checked, and backwards elimination strategy was used, 
when developing the models. When variables were removed, confounding was assessed at each 
stage. If there was a change in the effect estimate of the primary independent variable by 20% or 
more with the inclusion of a variable, the variable would be retained in the model as a 
confounder. All possible two-way interactions involving the primary independent variable and 
the variables of interest were assessed using a p-value of 0.05 for statistical significance. All 
analysis was carried out using SAS version 9.3.  
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3.3 Results 
3.3.1 Descriptive statistics 
In 2012–2013, 14.8% of the participating students from grades 10–12, self-identified as having 
used flavoured tobacco over the past 30-days in Canada. Past 30-day use of flavoured tobacco as 
a percentage was highest among males (18.8%), who attended 12th grade (17.4%), and who self-
reported being Aboriginal (23.9%), Hispanic (21.3%) and Black (19.0%). Also, youth who used 
flavoured tobacco products in the past 30-days, reported having one or more friends who smoked 
(68.3%), one or more siblings who smoked (91.2%), and one or more parents/guardians who 
smoked (63.9%). In terms of their weekly personal spending, 23.3% reported having greater than 
$100 per week to spend on themselves, while 8.7% reported having no personal weekly monies 
(Table 3.1). 
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Table 3.1: Descriptive characteristics of the study population among 10–12 grade school 
students in Canada, 2012–2013 
Variables Flavoured 
Tobacco Use (Past 
30 days) 
No Flavoured 
Tobacco Use (Past 
30 days) 
Total 
(N) 
Outcome Variable 
Flavoured Tobacco Use (Past 30-
days) 
 
14.77% 85.23% 19979 
Independent Variables 
Sex 
(n=19979) 
Female 10.9% 89.1% 10171 
Male 18.8% 81.2% 9808 
Grade 
(n=19979) 
10 12.7% 87.3% 7544 
11 15.0% 85.0% 6982 
12 17.4% 82.6% 5453 
Ethnicity 
(n=18818) 
White 14.5% 85.5% 14389 
Black 19.0% 81.0%     814 
Asian 7.5% 92.5% 1942 
Aboriginal 23.9% 76.1% 1270 
Latin American/ 
Hispanic 
21.3% 78.7% 403 
Friend Smokers 
(n=18048) 
None 4.6% 95.5% 9861 
One 12.1% 87.9% 2278 
Two 19.7% 80.3% 1571 
Three or more 36.5% 63.5% 4338 
Sibling Smokers 
(n=18141) 
None 11.0% 89.0% 14149 
One 23.2% 76.8% 2763 
Two 25.9% 74.1% 718 
Three or more 42.1% 57.9% 511 
Parent/Guardian 
Smokers 
(n=18921) 
 
None 10.4% 89.6% 10935 
One 16.5% 83.5% 4284 
Two 20.1% 79.9% 2107 
Three or more 27.3% 72.7% 1595 
Weekly Personal 
Spending 
(n=16546) 
 
Zero 8.7% 91.3% 2783 
$1-$5 12.5% 87.5% 869 
$6-$10 10.3% 89.7% 1199 
$11-$20 12.6% 87.4% 2594 
$21-$40 17.1% 82.9% 2639 
$40-$100 16.7% 83.3% 2733 
>$100 23.3% 76.7% 3729 
Self-Esteem 
(n=19923) 
High 14.6% 85.4% 12485 
Intermediate 14.3% 85.7% 6667 
Low  21.9% 78.1% 771 
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3.3.2 Logistic regression analysis 
Univariate analysis suggests that sex (p < 0.0001), grade (p < 0.0003), ethnicity (p < 0.0001), 
friends who smoke (p < 0.0001), siblings who smoke (p < 0.0001), parents/guardians who smoke 
(p < 0.0001) and weekly personal spending money (p < 0.0001) were significantly associated 
with flavoured tobacco use among students in grades 10–12. Odds ratios are shown in relation to 
a reference category for each variable (Table 3.2). 
Multivariable logistic regression analysis examined the odds of being a flavoured tobacco user. 
Male students were aOR=1.63 (95% CI: 1.36-1.95) times more likely to be flavoured tobacco 
users compared to females when adjusting for ethnicity, friends who smoke, siblings who smoke 
and weekly personal spending. In our final model (adjusted for sex, ethnicity, friends who 
smoke, siblings who smoke and weekly personal spending), the variables of “friends who 
smoke” showed a graded association of a student using flavoured tobacco as the number of 
friends who smoke increased from one (aOR = 2.20, 95% CI: 1.62-2.99) to two friends 
(aOR = 3.80, 95% CI: 2.71-5.31) and three or more friends who smoke (aOR = 7.08, 95% CI: 
5.66-8.86), when compared to students who reported having no friends who smoke. A similar 
pattern was seen with siblings who smoke, as individuals who had one sibling (aOR = 1.51, 95% 
CI: 1.22-1.88), two siblings (aOR = 1.55, 95% CI: 1.09-2.20) and three or more siblings who 
smoke (aOR = 3.40, 95% CI: 2.33-4.96) demonstrated a graded association with flavoured 
tobacco use, when compared to students with no siblings who smoke. When examining the 
association between weekly spending and flavoured tobacco use, individuals with the highest 
weekly spending (greater than $100 per week in personal spending) had the strongest association 
with flavoured tobacco use (aOR = 2.46, 95% CI: 1.82-3.33) compared to individuals with no 
weekly personal spending. There were no statistically significant associations with 
parent/guardian smokers or by high school grade (grade 10, 11, 12) and a student using flavoured 
tobacco (Table 3.3). 
It is important to note that complete case data was used in this analysis which resulted in a 
sample size of 13,139 from the initial 19,979 respondents. As a result there is potential for biases 
in our estimates.  
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Table 3.2: Univariate analysis of flavoured tobacco use among 10–12 grade school students 
in Canada, 2012–2013 
 
Variables Odds Ratio  
(95% CI: Lower to Upper) 
p-value 
Sex 
(Ref=Female) 
Males 1.73 (1.48-2.02) < 0.0001 
Grade 
(Ref=Grade 10) 
Grade 11 1.20 (1.00-1.44) 0.0003 
Grade 12 1.53 (1.24-1.87) 
Ethnicity 
(Ref = White) 
Black 0.83 (0.58-1.19) < 0.0001 
Asian 0.53 (0.39-0.71) 
Aboriginal 2.17 (1.74-2.70) 
Hispanic 1.49 (1.03-2.17) 
Friends Smokers  
(Ref = None) 
1 2.82 (2.05-3.88) < 0.0001 
2 5.28 (3.82-7.30) 
3 or more 10.47 (8.56-12.81) 
Siblings Smokers   
(Ref = None) 
1 2.82 (2.29-3.48) < 0.0001 
2 3.43 (2.59-4.54) 
3 or more 7.07 (5.01-9.97) 
Parents/Guardians 
Smokers  
(Ref = None) 
1 1.76 (1.44-2.15) < 0.0001 
2 2.25 (1.82-2.79) 
3 or more 3.63 (2.80-4.69) 
Weekly Personal 
Spending  
(Ref = Zero) 
$1-$5 1.05 (0.72-1.53) < 0.0001 
$6-$10 1.16 (0.81-1.68) 
$11-$20 1.73 (1.28-2.34) 
$21-$40 2.33 (1.75-3.09) 
$41-$100 2.23 (1.65-3.00) 
> $100 3.76 (2.93-4.81) 
Self-Esteem  
(Ref = High) 
Low 1.66 (1.21-2.28) 0.0004 
Intermediate 0.87 (0.74-1.02) 
Flavoured Tobacco Use = 1 if: Menthol cigarette or Flavoured little cigar or cigarillo or 
Flavoured cigar or Flavoured tobacco in a water-pipe (hookah) was used over the past 30 
days. 
Flavoured Tobacco Use = 0 if: I did not use any of these things (above) in the last 30 days  
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Table 3.3: Factors associated with flavoured tobacco use by logistic regression analyses among 
10–12 grade school students in Canada, 2012–2013 (n=13,139) 
Variables Adjusted Odds Ratio (aOR) 
(95% CI: Lower to Upper) 
p-value 
Ethnicity 
(Ref = White) 
Black 0.94 (0.60-1.45) 0.0470 
Asian 0.65 (0.46-0.92) 
Aboriginal 1.19 (0.88-1.60) 
Hispanic 1.32 (0.84-2.08) 
Sex 
(Ref=Female) 
Males 1.63 (1.36-1.95) < 0.0001 
Friends 
Smokers  
(Ref = None) 
1 2.20 (1.62-2.99) < 0.0001 
2 3.80 (2.71-5.31) 
3 or more 7.08 (5.66-8.86) 
Siblings 
Smokers   
(Ref = None) 
1 1.51 (1.22-1.88) < 0.0001 
2 1.55 (1.09-2.20) 
3 or more 3.40 (2.33-4.96) 
Weekly 
Personal 
Spending  
(Ref = Zero) 
$1-$5 1.05 (0.68-1.62) < 0.0001 
$6-$10 1.12 (0.71-1.76) 
$11-$20 1.23 (0.87-1.76) 
$21-$40 1.76 (1.26-2.45) 
$41-$100 1.62 (1.17-2.26) 
> $100 2.46 (1.82-3.33) 
Flavoured Tobacco Use = 1 if: Menthol cigarette or Flavoured little cigar or cigarillo 
or Flavoured cigar or Flavoured tobacco in a water-pipe (hookah) was used over the 
past 30 days. 
Flavoured Tobacco Use = 0 if: I did not use any of these things (above) in the last 30 
days 
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3.4 Discussion 
This study sought to determine the prevalence and characteristics associated with the use of 
flavoured tobacco among a national sample of Canadian students in grades 10 through 12. It 
provides insight and adds knowledge to our understanding of flavoured tobacco use among youth 
in Canada along two discrete but interrelated perspectives/aspects (demographic and social). 
From a demographic perspective, our study found that 14.8% of the students reported using 
flavoured tobacco. This is similar to the prevalence reported among high school students in the 
US25 and previous studies in Canada.6,26 Flavoured tobacco is becoming increasingly popular 
among students as evidenced by the fact that one out of every three Canadian youth has tried it7 
and sales have increased by eightfold in six years.21 This may be a reflection of the widespread 
belief by youth that flavoured tobacco is a better alternative to regular tobacco, less harmful to 
their health and more fun to use.15,27 Our findings also demonstrate a progressive rise in 
flavoured tobacco use with increasing grades 10–12 among Canadian students (16–18 years old). 
This is a period of identity development, increased curiosity and risk taking behaviour.28 The 
tobacco industry, exploits the inherent vulnerability of this transitional period by focusing their 
trendy marketing and advertising campaigns on themes that resonate with youth such as 
independence, sophistication, fun and rebellion.9 
In our study, male students were significantly more likely to use flavoured tobacco compared to 
females. This was consistent with evidence reported elsewhere in the literature.11-13 It is possible 
that male students have higher risk-taking proclivities/behaviours along with easier access and 
higher affordability levels to flavoured tobacco when compared to females. Students who self-
identified as Aboriginal or Hispanic did not have a statistically significant increased odds of 
using flavoured tobacco when compared to White students, but had a higher prevalence of use. 
Our results are corroborated by several Canadian studies that show an increased burden of 
smoking among Aboriginal youth.29,30 However, there is not much in the literature detailing the 
smoking situation of Hispanic youth in Canada. This is an area that requires further study as 
evidence from Mexico31,32 and the US9,11 shows that Hispanic youth are at an increased risk for 
smoking behaviours, including the use of flavoured tobacco.33 
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From a social perspective, we found a significant association between the number of siblings or 
friends who smoke and the likelihood of a student using flavoured tobacco after adjusting for all 
other covariates. Interestingly, our study found peers to have a more pronounced influence on 
students’ use of flavoured tobacco when compared to their siblings and even their 
parents/guardians. There are multiple mechanisms that may help explain this finding. It may be 
the result of the increased amount of time youth spend with their peers34 and the opportunities for 
social learning,35 ease of access to flavoured tobacco35–37 and direct pressures to identify, bond 
and gain their respect and acceptance at this critical time of their development.38 
Finally, we found that the more money a student had available to spend in a week, the higher the 
likelihood of them using flavoured tobacco. Several studies have associated youth’s access to 
spending money with their risk of smoking.6, 39, 40 A study in Ontario, Canada, found that even 
small differences in weekly spending allowance had an incremental and significant impact on the 
smoking status among youth. It reported that students who had less than $10 per week were 
significantly less likely to be smokers, those with $20 per week were significantly more likely to 
be experimental smokers, and students with more than $30 per week were significantly more 
likely to be current smokers.40 
Study’s strengths and limitations 
Flavoured tobacco use as defined for the purposes of this study represented use in the past 30-
days. This time limitation may not allow us to adequately determine the volume or frequency of 
use. Secondly, there were no objective measures of flavoured tobacco use since all the measures 
in the study were self-reports. Third, the YSS is a school-based survey and therefore, youth who 
do not attend school were excluded from our sample. Lastly, the study used of a cross-sectional 
design and therefore, it is unable to draw causal inferences between the variables studied and 
flavoured tobacco use. Despite the aforementioned limitations, this study also has several 
significant strengths. It used a national sample that was large in size and representative in scope 
and specifically looked to identify the prevalence and demographic and social characteristics in 
the use of flavoured tobacco among Canadian students in grades 10–12. 
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3.5 Conclusions 
The results of our study show that flavoured tobacco use is a public health concern and has a 
strong appeal among youth in Canada. This is a particularly troubling finding, especially in light 
of the fact that there is a national ban on certain flavoured tobacco products. To be effective, 
strategies specifically tailored for youth using flavoured tobacco would require appropriate 
educational/prevention initiatives, more comprehensive legislation and better regulatory 
mechanisms. These interventions are urgently needed in order to prevent erosion and safeguard 
the significant gains made in our efforts to reduce smoking rates in Canada. 
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4. CHAPTER 4: SEXUAL ORIENTATION AND SMOKING 
PREFERENCES: RESULTS FROM A POPULATION-BASED SURVEY 
IN CANADA 2009-20142 
Purpose: The purpose of this study was to use a large, representative, population-based survey to 
assess the characteristics and examine the associations between sexual orientation (heterosexual, 
lesbian/gay, or bisexual) and smoking status (current, former, and never smokers) among 
Canadians. 
Methods: This is a cross-sectional study. It used and analyzed the combined data from the 2009-
2014 Canadian Community Health Survey (CCHS). The primary outcome variable was cigarette 
smoking. The primary independent variable was sexual orientation. The independent variables 
included socio-demographics, environmental tobacco exposure and mental health status. 
Results: This study found that the majority of bisexuals reported being current smokers 
(39.68%), while most lesbians/gays were former smokers (37.63%) and most heterosexuals were 
never smokers (40.65%). Multinomial logistic regression modeling found sexual orientation to 
be significantly associated with cigarette smoking. Specifically, bisexual females and lesbians 
were more likely to be current smokers rather than never smokers compared to heterosexual 
females (aOR: 2.68, 95% CI: 1.99-3.61 and aOR: 1.92, 95% CI: 1.29-2.85, respectively). There 
was no evidence to suggest that gay or bisexual males were more likely to be current smokers 
rather than never smokers compared to heterosexual males. 
Conclusions: Sexual minority populations are diverse and highly vulnerable to smoking. The 
results of our study suggest that significant disparities in smoking exist within and between 
sexual minority and heterosexual populations. 
Keywords: Sexual orientation; smoking; Canada 
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2 Bird Y, Wong J, Mahmood R, Nwankwo C, Moraros J. Sexual orientation and smoking: Results from a 
Population-Based Survey in Canada 2009-2014. Patient Prefer Adherence. February 2020. Submitted for 
publication, currently under review. 
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4.1 Introduction 
Cigarette smoking remains a major public health concern. It is estimated that every year, 
approximately 40,000 Canadians1 die due to smoking related diseases, leading to 16 billion 
dollars in total economic costs.2 In 2015, approximately 5.4 million Canadians were either daily 
or occasional smokers.3 Although there is extensive research on smoking prevalence and 
behaviours among the general population, there is limited research on the smoking preferences of 
sexual minorities in Canada with the majority of studies examining specific populations (i.e. 
youth, MSM, specific geographical areas). According to the 2012 Canadian Community Health 
Survey – Mental Health (CCHS-MH), 3.9% of Canadians reported being a sexual minority 
(specifically, lesbian, gay, or bisexual [LGB]).4 Historically, sexual minority individuals are a 
vulnerable population that have been selectively targeted by the tobacco industry5-8 and 
disproportionally impacted by tobacco-related diseases.9 
Emerging research suggests that sexual minority individuals are at an increased risk for a number 
of adverse health behaviours, including cigarette smoking, when compared to heterosexuals.10-12  
This may be of particular interest to tobacco prevention and control initiatives, as a growing 
body of evidence, mainly from the United States, found that sexual minority populations smoke 
cigarettes at significantly higher rates (20%-50%) than the national average (18%).11-15 
Specifically, it has been reported that sexual minority individuals have a higher prevalence of 
being current and former smokers,16,17 start smoking at a younger age,18 and smoke more 
frequently.19,20 Within sexual minority subgroups, it has been noted that bisexuals smoke 
cigarettes at higher rates than their gay and lesbian counterparts.21 In particular, bisexual women 
were found to have higher rates of cigarette use compared with lesbians, even after adjusting for 
other risk factors.11,21,22 
The disparities found among and within sexual minority populations with regard to cigarette 
smoking may be attributed in part to issues of marginalization, discrimination, disclosure and 
internalized homophobia.23 Studies have shown that sexual minorities are more likely to 
experience increased exposure to stress, stigma, depression, isolation, victimization, socialization 
in smoky areas, aggressive tobacco marketing, and substance use.23-25 The minority stress theory 
posits that LGB individuals  may use maladaptive coping behaviors because they experience 
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chronic, social and structural stressors, which helps explain the higher rates of cigarette use 
observed in this population.26-28 However, as public levels of awareness and acceptance of 
homosexuality have increased in recent years,29 the health disparities observed in cigarette 
smoking have been unevenly reduced, mainly benefiting gay men.16 Lesbian and especially 
bisexual women are still two to three times more likely to smoke compared to heterosexual 
women.30 
A few Canadian studies have investigated the link between sexual orientation and cigarette 
smoking preferences and found that LGB individuals are significantly more likely to smoke, 
when compared to their heterosexual peers.9,10,31,32 One study reported that LGB adolescents had 
a higher prevalence of daily cigarette use (22%), when compared with their heterosexual 
counterparts (11%).10 Another study found that lesbian and bisexual women were more likely to 
report daily smoking and other risky behaviors than heterosexual women.9 However, these 
studies were limited by a number of factors including small sample sizes, assessment of the 
sexual minority population as a single aggregate group and/or evaluation of only specific 
subgroups (e.g. high school students, men who have sex with men), sex (women only) and/or 
geographic locations (e.g. Toronto, Greater Vancouver Area and Atlantic Canada).  Therefore, 
the purpose of this study was to use a large, representative, population-based survey to assess the 
characteristics and examine the associations between sexual orientation (heterosexual, lesbian, 
gay, or bisexual) and smoking preferences (current, former, and never smokers) in Canada. 
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4.2 Methods 
4.2.1 Instrument 
This study used and analyzed the combined data from the 2009-2014 Canadian Community 
Health Survey (CCHS). CCHS is an annual, nationally representative, population-based survey, 
which uses a multistage stratified cluster probability sampling and aims to assess the health 
status, health service usage and determinants of health among people living in Canada.33 This 
research was conducted at the Saskatchewan Research Data Centre (SKY-RDC), a part of the 
Canadian Research Data Centre Network (CRDCN). This service is provided through the 
support of the University of Saskatchewan, the Canadian Foundation for Innovation, the 
Canadian Institutes of Health Research, the Social Science and Humanity Research Council, and 
Statistics Canada. All views expressed in this work are our own. 
4.2.2 Measures 
Outcome variable: The outcome variable was cigarette smoking. In CCHS, smoking was 
assessed by asking participants to respond to whether they were: 1) daily, 2) occasional, 3) 
always occasional, 4) former daily, 5) former occasional and 6) never smokers. In this study, 
smoking was re-categorized as follows: 1) current smokers (daily, occasional or always 
occasional, past 30-day smokers), 2) former smokers (former daily or former occasional), and 3) 
never smokers (never).  
Primary independent variable: The primary independent variable was sexual orientation (e.g. 
whether an individual self-identifies as gay, lesbian, bisexual, or heterosexual). Sexual 
orientation was determined for each participant based on their answer to the following survey 
question: “Do you consider yourself to be: heterosexual (sexual relations with people of the 
opposite sex), or homosexual (that is lesbian or gay, sexual relations with people of your own 
sex), or bisexual (sexual relations with people of both sexes).”  
Other independent variables: In this study, selection of additional variables was based on review 
of the scientific literature11,13,14 and included: 
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1. Socio-demographics:  Age (18-29; 30-44; and 45-59 years old), sex (female, male), 
education (less than secondary school graduation; secondary school graduation; some post-
secondary education; and post-secondary graduation), and relationship status (married or 
living common-law; widowed, separated or divorced; and single, never married). 
2. Environmental tobacco smoke (ETS) exposure: Participants were asked to answer the 
following question: “Including both household members and regular visitors, does anyone 
smoke inside your home, every day or almost every day?” (Yes, No). 
3. Mental health status: Participants were also asked to rate their mental health (“Excellent, 
Very Good, or Good and Fair or Poor”). Categories were collapsed similar to a previous 
study4 into two groups: excellent, very good, or good; and fair or poor, due to cell size 
limitations. 
4.2.3 Statistical analysis and model building 
The analysis was conducted at the research data centre at the University of Saskatchewan (SKY-
RDC). CCHS data from the 2009-2014 cycles were merged and analyzed using a pooled 
approach. The pooled approach (combined cycles from 2009-2014) was adopted because even 
though the CCHS has a large sample size, our analysis used a small population (sexual 
minorities) and using just one survey cycle would lead to poorer outcome estimation due to 
power, sampling error, and missing data.34 Pooling involves combined the cycles from 2009, 
2010, 2011, 2012, 2013 and 2014 into one large analytic sample.35 Pooling of the cycles of the 
CCHS (2009-2014) was appropriate as the questions asked in these surveys were the same for 
the variables included (outcome and independent) and there was no changes in the coverage or 
sampling methodology over this time period.35 The weights provided by the CCHS were scaled 
by a factor of 1/6 to account for the new analytic sample which serves as one large random 
sample derived from six initial random samples.35 Pooling the CCHS cycles yielded a large 
enough sample size to conduct the analysis and provided sufficient power to provide higher 
quality estimates compared to using a single cycle.35 
CCHS cycles are random-digit dialing telephone survey samples with computer-assisted 
interviewing. CCHS excludes First Nations members living on reserves, persons living in 
institutions (e.g., penitentiaries), and full-time members of the Canadian Armed Forces and the 
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Royal Canadian Mounted Police.33 In our study, survey participants were Canadians ages 18-59 
years old which is the measure used by the CCHS which is partially due to the sensitive nature of 
sexual orientation related questions and non-response by older adults, and is consistent with 
population based surveys with questions on sexual orientation conducted in the USA,36 who 
answered all relevant questions on smoking status, sexual orientation, socio-demographics, ETS 
exposure and mental health status. The same questions were examined across all CCHS survey 
cycles to ensure they were consistently administered, coded and weighed. Individuals with 
missing data were excluded from our analysis (5.08%) (Figure 4.1).  
 
Total Sample from 
CCHS 2009-2014
Canadian adults aged 
18-59 years old
Final analytic sample
Excluded due to 
missing data (5.08%)
Excluded individuals 
under 18 years and 
over 59 years old
Figure 4.1: Flow diagram showing the final analytic sample from CCHS 2009-2014. 
Please note: Sample size numbers were not authorized for release due to confidentiality 
concerns by the Research Data Centre at the University of Saskatchewan (SKY-RDC). 
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Descriptive statistics and cross-tabulations were used to summarize the basic characteristics of 
the data. Univariable (unadjusted) analyses were conducted to determine whether there was an 
association between the outcome (smoking status) and the independent variables. Model 
selection was conducted using purposeful model selection.37 Firstly, unadjusted analysis was 
conducted  to determine the crude association between each of the independent variables and 
smoking status using a p-value ≤ 0.25 indicating statistical significance.37 Variables that were 
statistically significant in unadjusted analysis were included in the initial multivariable model. 
Multivariable models were developed using multinomial logistic regression with manual 
backward elimination with a p-value ≤ 0.05 indicating statistical significance. When a variable 
was removed, confounding was assessed by comparing the values of the estimated regression 
coefficients (β) of the primary independent variable (sexual orientation) in each stage whereby 
Δβ ≥ 20% indicated confounding. If a variable was a confounder, it was kept in the model.37  
Overall, three models were reported: Model 1 - examined the unadjusted (crude) association 
between smoking status and sexual orientation. Model 2 - examined the association between 
smoking and sexual orientation, while adjusting for the effects of age and sex. Model 3 - 
examined the association between smoking and sexual orientation, while adjusting for the effects 
of socio-demographics, exposure to ETS and mental health status. Goodness of fit of the models 
was assessed by examining deviance and Pearson chi-square statistics similar to previous 
multinomial logistic regression models.38,39 Datasets were merged using SPSS Statistics software 
version 24.0 (IBM Corp., Armonk, NY, USA), while analysis was conducted using SAS 9.4 
(SAS Institute Inc., Cary, NC, USA). 
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4.3 Results 
4.3.1 Descriptive statistics 
In this study, we report our findings on a final, analytic, weighted sample of approximately 
390,000 participants, which represents approximately 19 million Canadians.  Of these, 
approximately 2.5% of Canadians aged 18-59 years old, identified as being sexual minorities and 
specifically, 1.4% reported being lesbians/gays and 1.1% reported being bisexual. This is in line 
with the nationally reported rates of sexual minorities in Canada.40 
The frequency distributions by smoking status for sexual orientation and other independent 
variables (age, sex, education, relationship status, environmental tobacco smoke, mental health 
and income) overall and stratified by sex are presented in Table 4.1. Bisexuals (39.68%) had the 
highest prevalence of current smokers followed by homosexuals (31.37%) and heterosexuals 
(23.82%). Individuals aged 18-29 years old had the highest rates of current smokers (25.94%) 
when compared to respondents aged 30-44 years old (23.32%) and 45-59 years old (23.25%). A 
higher proportion of males were current smokers (27.60%) compared to females (20.44%). 
Survey respondents with less than secondary school graduation had the highest prevalence of 
current smokers (44.18%) compared to those who reported secondary school graduation 
(28.99%), some post-secondary school education (27.36%) and post-secondary graduation 
(19.20%). Individuals who were widowed or divorced or separated had higher rates of current 
smokers (34.80%) when compared to those who were single, never married (29.23%) and 
married or common law (20.04%). Respondents who were exposed to environmental tobacco 
smoke reported higher rates of current smoking (62.59%) compared to those who did not 
(16.33%). Individuals reporting fair or poor mental health had a higher prevalence of current 
smokers (39.38%) compared to those reporting excellent or very good or good mental health 
(23.09%) (Table 4.1). 
The frequency distributions by sexual orientation for smoking status and other independent 
variables (age, sex, education, relationship status, environmental tobacco smoke, mental health 
and income) are presented in Table 4.2. Most heterosexuals (37.76%) and lesbians/gays 
(38.86%) were aged 45-59 years old, while 53.90% of bisexuals were aged 18-29 years old. 
There were more gays (62.90%) than lesbians (37.10%), while most bisexuals were females 
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(69.90%). When looking at the relationship status, the majority of heterosexuals reported being 
either married or living in a common-law relationship (62.80%), while most gays/lesbians 
(56.67%) and bisexuals (60.40%) were single. When examining education, bisexuals reported 
the lowest rates of post-secondary graduation (48.88%). Bisexuals also reported the highest rate 
of exposure to ETS (16.39%), followed by guys/lesbians (12.52%) and then heterosexuals 
(9.58%). Finally, bisexuals reported the highest proportion of individuals with fair or poor 
mental health (18.61%) (Table 4.2).  
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Table 4.1: Descriptive statistics by smoking status 
 
 Entire Population 
 
Females Males Total 
(Weighted) 
 Current 
Smoker 
n=4605955 
Former 
Smoker 
n=6787804 
Never 
Smoker 
n=7721950 
Current 
Smoker 
n=2038293 
Former 
Smoker 
n=3352990 
Never 
Smoker 
n=4578617 
Current 
Smoker 
n=2747794 
Former 
Smoker 
n=3656506 
Never 
Smoker 
n=3552075 
 
Primary Variable           
Sexual 
Orientation   
(n=19130000) 
Heterosexual 
Lesbian/Gay 
Bisexual 
23.82% 
31.37% 
39.68% 
 
35.53% 
37.63% 
30.63% 
 
40.65% 
31.01% 
29.69% 
20.20% 
27.38% 
40.41% 
 
33.98% 
42.35% 
30.33% 
 
45.82% 
30.27% 
29.26% 
27.44% 
33.72% 
38.00% 
 
37.09% 
34.84% 
31.32% 
 
35.47% 
31.44% 
30.69% 
18660000 
268249 
209715 
Other Variables           
Age 
(n=19130000) 
18-29 years old 
30-44 years old 
45-59 years old 
 
25.94% 
23.32% 
23.25% 
23.74% 
34.86% 
43.84% 
50.32% 
41.81% 
32.91% 
21.57% 
19.31% 
20.67% 
 
22.90% 
33.56% 
41.39% 
55.53% 
47.13% 
37.94% 
30.20% 
27.36% 
25.88% 
24.57% 
36.18% 
46.32% 
45.24% 
36.46% 
27.80% 
5298413 
6649453 
7186998 
Biological Sex 
(n=19130000) 
Female  
Male 
 
20.44% 
27.60% 
33.63% 
36.73% 
45.92% 
35.68% 
 9580310 
9554554 
Education 
(n=18990000) 
Less Secondary School Grad. 
Secondary School Grad. 
Some Post-Secondary 
Post-Secondary Grad. 
 
44.18% 
28.99% 
27.36% 
19.20% 
27.93% 
31.90% 
30.39% 
37.81% 
27.89% 
39.11% 
42.24% 
42.98% 
39.16% 
25.27% 
24.84% 
16.31% 
25.63% 
31.68% 
28.66% 
35.85% 
35.21% 
43.05% 
46.49% 
47.84% 
48.04% 
32.50% 
29.86% 
22.28% 
 
29.70% 
32.10% 
32.11% 
39.90% 
22.26% 
35.40% 
38.03% 
37.82% 
1661265 
3587156 
1445533 
12300000 
Relationship 
Status 
(n=19100000) 
Married/Common-Law  
Widowed/Divorced/Separated 
Single, Never Married 
 
20.04% 
34.80% 
29.23% 
40.17% 
36.26% 
24.55% 
39.78% 
28.94% 
46.22% 
16.80% 
30.71% 
24.92% 
37.84% 
36.23% 
23.04% 
45.37% 
33.06% 
52.04% 
23.36% 
41.42% 
32.85% 
42.56% 
36.31% 
25.83% 
34.08% 
22.27% 
41.32% 
11860000 
1597068 
5646443 
Environmental 
Tobacco 
Smoke 
(n=18360000) 
Yes 
No 
62.59% 
16.33% 
18.38% 
38.62% 
19.02% 
45.05% 
61.16% 
13.56% 
17.49% 
36.44% 
21.35% 
50.00% 
63.93% 
19.20% 
19.22% 
40.87% 
16.85% 
39.93% 
1778481 
16580000 
Mental Health 
(n=19110000) 
Excellent, Very Good, Good 
Fair or Poor 
 
23.09% 
39.38% 
35.64% 
30.48% 
41.27% 
30.14% 
19.43% 
36.12% 
34.15% 
29.14% 
46.42% 
34.73% 
26.73% 
43.29% 
37.12% 
32.10% 
36.15% 
24.61% 
17980000 
1131641 
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Table 4.2: Descriptive Statistics by Sexual Orientation  
 
 
 
Heterosexual 
(n=18660000) 
 
 
Lesbian/Gay 
(n=268249) 
 
 
Bisexual 
(n=209715) 
Total 
(Weighted) 
Outcome Variable 
Smoking Status 
(n=19120000)   
Current Smoker 
Former Smoker 
Never Smoker 
23.82% 
35.53% 
40.65% 
31.37% 
37.63% 
31.01% 
39.68% 
30.63% 
29.69% 
4605955 
6787804 
7721950 
Independent Variables 
Age 
(n=19130000) 
18-29 years old 
30-44 years old 
45-59 years old 
27.35% 
34.89% 
37.76% 
30.71% 
30.43% 
38.86% 
53.90% 
27.73% 
18.37% 
5298413 
6649453 
7186998 
Sex 
(n=19130000) 
Female  
Male 
50.03% 
49.97% 
37.10% 
62.90% 
69.90% 
30.10% 
9580310 
9554554 
Education 
(n=18990000) 
Less Than Secondary School Graduation 
Secondary School Graduation 
Some Post-Secondary 
Post-Secondary Graduation 
8.75% 
18.89% 
  7.55% 
64.81% 
4.75% 
14.54% 
  7.42% 
73.28% 
13.78% 
24.00% 
13.35% 
48.88% 
1661265 
3587156 
1445533 
12300000 
Relationship Status 
(n=19100000) 
Married/Common-Law  
Widowed/Divorced/Separated 
Single, Never Married 
62.80% 
8.37% 
28.82% 
36.49% 
6.84% 
56.67% 
30.37% 
9.23% 
60.40% 
11860000 
1597068 
5646443 
Environmental 
Tobacco Smoke 
(n=18360000) 
Yes 
No 
9.58% 
90.42% 
12.52% 
87.48% 
16.39% 
83.61% 
1778481 
16580000 
Mental Health 
(n=19110000) 
Excellent, Very Good, or Good 
Fair or Poor 
94.26% 
5.74% 
91.39% 
8.61% 
81.39% 
18.61% 
17980000 
1131641 
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4.3.2 Multinomial logistic regression models 
Three models are presented using multinomial logistic regression analyses to examine the 
association between sexual orientation and smoking overall, among females and among males 
(Model 1: unadjusted, Model 2: adjusted for age and sex and Model 3: adjusted for socio-
demographics, exposure to ETS and mental health status). The results are presented in Table 4.3. 
Model 1: This model examined the unadjusted association between smoking and sexual 
orientation. Sexual orientation was significantly associated with smoking. Specifically, 
lesbians/gays were more likely to be current smokers than never smokers (OR: 1.42, 95% CI: 
1.41-1.44) and former smokers than never smokers (OR: 1.38, 95% CI: 1.36-1.39) compared to 
heterosexuals. Additionally, bisexuals were more likely to be current smokers rather than never 
smokers (OR: 2.23, 95% CI: 2.20-2.25) and former smokers than never smokers (OR: 1.19, 95% 
CI: 1.18-1.21) compared to heterosexuals. Bisexual females were more likely to be current 
smokers than never smokers (OR: 3.10, 95% CI: 3.06-3.14) and former smokers than never 
smokers (OR: 1.42, 95% CI: 1.40-1.43) compared to heterosexuals. Bisexual males were more 
likely to be current smokers than never smokers (OR: 1.44, 95% CI: 1.41-1.47). The large 
sample size used in this analysis likely contributes to the narrow 95% confidence intervals seen 
in the unadjusted models, as increasing sample size decreases the width of confidence intervals. 
Model 2: This model examined the association between smoking and sexual orientation, while 
adjusting for the effects of age and sex. It found that lesbians were more likely to be current 
smokers rather than never smokers (aOR: 1.90, 95% CI: 1.23-2.93) and former smokers rather 
than never smokers (aOR: 1.99, 95% CI: 1.37-2.88) compared to heterosexuals. Bisexual 
females were more likely to be current smokers rather than never smokers (aOR: 3.30, 95% CI: 
2.38-4.56) and former smokers rather than never smokers (aOR: 1.89, 95% CI: 1.35-2.64) 
compared to heterosexuals. There was no evidence to suggest that gay or bisexual males were 
more likely to be current smokers rather than never smokers compared to heterosexual males.  
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Model 3: This model examined the association between smoking and sexual orientation, while 
adjusting for the effects of socio-demographics, exposure to ETS and mental health status. 
Results showed that lesbians were more likely to be current smokers than never smokers (aOR: 
1.92, 95% CI: 1.29-2.85) and former smokers than never smokers (aOR: 2.11, 95% CI: 1.54-
2.89) compared to heterosexuals. Bisexual females were more likely to be current smokers rather 
than never smokers (aOR: 2.68, 95% CI: 1.99-3.61) and former smokers than never smokers 
(aOR: 1.95, 95% CI: 1.47-2.59) compared to heterosexuals. There was no evidence to suggest 
that gay or bisexual males were more likely to be current smokers than never smokers or former 
smokers than never smokers compared to heterosexual males. 
74 
 
Table 4.3: Multinomial logistic regression models examining the association between smoking and sexual orientation  
 
 Entire Population 
(n=18,157,938) 
Females 
(n=9,203,962) 
Males 
(n=8,953,976) 
Currenta vs.  
Never Smokerc 
OR (95% CI) 
Formerb vs.  
Never Smoker 
OR (95% CI) 
Current vs.  
Never Smoker 
OR (95% CI) 
Former vs.  
Never Smoker 
OR (95% CI) 
Current vs.  
Never Smoker 
OR (95% CI) 
Former vs.  
Never Smoker 
OR (95% CI) 
Model 1* 
Sexual 
Orientation 
(Ref: 
Heterosexual) 
 
Lesbian/Gay 1.42  
(1.41-1.44) 
1.38 
(1.36-1.39) 
1.88 
(1.85-1.91) 
1.90 
(1.87-1.93) 
1.09 
(1.07-1.10) 
1.04 
(1.03-1.05) 
Bisexual 2.23 
(2.20-2.25) 
1.19 
(1.18-1.21) 
3.10 
(3.06-3.14) 
1.42 
(1.40-1.43) 
1.44 
(1.41-1.47) 
0.98 
(0.96-1.00) 
Model 2** 
Sexual 
Orientation 
(Ref: 
Heterosexual) 
Lesbian/Gay 1.35  
(0.99-1.85) 
1.38 
(1.04-1.82) 
1.90  
(1.23-2.93) 
1.99 
(1.37-2.88) 
1.09  
(0.83-1.44) 
1.07 
(0.84-1.38) 
Bisexual 2.61  
(1.88-3.61) 
1.66 
(1.19-2.31) 
3.30  
(2.38-4.56) 
1.89 
(1.35-2.64) 
1.47  
(0.96-2.25) 
1.14 
(0.75-1.74) 
Model 3*** 
Sexual 
Orientation 
(Ref: 
Heterosexual) 
Lesbian/Gay 1.49 
(1.18-1.90) 
1.48 
(1.21-1.80) 
1.92 
(1.29-2.85) 
2.11 
(1.54-2.89) 
1.30 
(0.99-1.71) 
1.16 
(0.92-1.47) 
Bisexual 2.24 
(1.75-2.88) 
1.69 
(1.33-2.14) 
2.68 
(1.99-3.61) 
1.95 
(1.47-2.59) 
1.37 
(0.89-2.11) 
1.18 
(0.79-1.74) 
a Current smoker denotes daily, occasional or always occasional smokers 
b Former smoker denotes former daily or former occasional 
c Never smoker denotes never smoked 
* Model 1: Unadjusted OR for smoking status by sexual orientation 
** Model 2: aOR for smoking status by sexual orientation adjusting for age and sex for entire population; female and male model 
similar except for the sex variable 
*** Model 3: aOR for smoking status by sexual orientation adjusting for age, sex, education, relationship status, exposure to 
environmental tobacco smoke and mental health status; female and male model similar except for the sex variable 
Note: Weighted sample sizes presented; OR = odds ratio; aOR = adjusted odds ratio; CI = confidence interval; Ref = reference 
group; italics indicates not significant (p-value ≥ 0.05)
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4.4 Discussion 
To the best of our knowledge, this is the first population-based study to examine cigarette 
smoking and explore for differences across sexual orientation, age and sex among adult 
Canadians. This study builds upon our limited knowledge on cigarette smoking and health 
disparities among sexual minorities in Canada. It helps inform and potentially guide uniquely 
tailored tobacco cessation and prevention efforts to benefit LGB subpopulations, which are at 
higher risk for cigarette smoking and negative health outcomes and yet have been largely 
overlooked and understudied in the scientific literature. 
In our study, lesbians/gays (31.4%) and bisexuals (39.7%) had a higher proportions of being 
current smokers, when compared to heterosexuals (23.8%). Our findings are supported by 
previous studies, which show lesbians/gays and especially bisexuals to have higher rates of 
smoking, when compared to heterosexuals.11,41-43  
Biological sex and sexual orientation differences in cigarette smoking emerged in our study. 
Among females, lesbians were approximately two times more likely to be current smokers rather 
than never smokers, when compared to heterosexual females. Similarly, this association was 
nearly three times more likely among bisexual females, when compared to heterosexual females. 
Our findings are corroborated by those reported in previous studies.24,44 When examining males, 
we did not find a statistically significant association between sexual orientation and smoking. 
There is conflicting evidence in the literature regarding the influence of sexual orientation on 
smoking among males with certain studies suggesting an association exists,18,45 while other 
studies suggest there is no association.42,46 However, when we looked at the proportion of male 
current smokers in our study, gays and bisexuals had a higher prevalence of smoking than 
heterosexuals.  
Our study results show that even after controlling for known risk factors (education, relationship 
status, ETS exposure and mental health status), sexual orientation remained significantly 
associated with smoking among females (lesbian and bisexual) but not for males (gay and 
bisexual). There are different possible explanations for these biological sex-based differences. 
Female sexual minorities may have a dual-disadvantaged status by being both a sexual minority 
and female25 leading to increased stressors compared to male sexual minority counterparts. 
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Lesbian and bisexual women are disproportionately more susceptible to being influenced by 
tobacco marketing compared to heterosexual women, while similar trends are not seen among 
gay and bisexual men.47 While a study found that bisexual and lesbian women reported smoking 
their first cigarette at younger ages than heterosexual women and this relationship was 
significantly more pronounced compared to what was seen among men.18 This is an important 
finding as research has shown that the majority of adult smokers started smoking as teenagers 
and a younger age of smoking onset increases the risk of daily smoking, smoking intensity, 
nicotine dependence and results in more difficulties in smoking cessation.25,48 Dual disadvantage 
theory, tobacco marketing and age of smoking their first cigarette are all factors that may 
partially explain the biological sex-based disparities observed in the LGB community.  
We found that bisexual females in particular have a higher prevalence of cigarette use, even 
when compared with lesbian women and gay or bisexual men. These results help confirm 
previous findings that bisexual women may be at highest risk11,22,49 and support the hypothesis 
that there is within-group variation in cigarette use among the sexual minority subpopulations, 
even after adjusting for demographic and socioeconomic factors.11,14 When examining 
differences between lesbian and bisexual women, bisexual women have different demographic 
characteristics and one study found they have a different psychosocial profile which may lead to 
increased tobacco use.50 
This has important implications for tobacco control policy and practice, pointing to the need to 
generally, increase outreach efforts within the sexual minority communities and specifically, 
consider tailoring messaging toward its most vulnerable subgroup, bisexual women. 
Implications for public health research 
In Canada, there is paucity of population-based studies that provide insight and improve our 
understanding into sexual minority health and risky behaviours, including cigarette smoking.  
Our study findings are seminal in scope and context within the Canadian population. Future 
research efforts need to focus on several key areas. It will be important to study whether the adult 
smoking behaviours we observed in our study, start at an early age among sexual minorities in 
Canada and identify the mediators that support it into adulthood. Additionally, the heterogeneity 
in cigarette smoking according to sex and sexual orientation underscores the need to design 
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surveys that permit us to study the unique risk factors that are associated with the observed 
disparities among intragroup sexual minorities (lesbians/gays vs bisexuals vs heterosexual), 
better measure the multiple dimensions of sexual orientation  (sexual behaviour, sexual attraction 
and sexual identity), and consider between-sex differences among additional subpopulations 
(transsexual, transgender, queer and two-spirited) and ethnic groups (White, Black, Asian, Arab, 
Latino and Aboriginal) in Canada. 
Strengths and limitations 
The several strengths of this study. This study helps highlight the inadequacy in using the terms 
“sexual minority” or “LGB” to broadly group different heterogeneous populations together even 
though they are unique in composition, behaviour and risk profile for cigarette smoking.  
Additional strengths include the use of a randomly selected, probability-based, Canadian-wide 
population sample that directly asks about sexual orientation. It uses a previously validated 
survey design and examines an important issue among highly vulnerable sexual minority 
populations. A limitation of this study was the low frequency of self-reported sexual minority 
individuals in Canada. To address this limitation, we had to re-categorize some variables to 
improve effect estimates but it limited the ability to incorporate additional variables. The survey 
only asked about sexual identity but research has shown that attention also needs to be directed 
to sexual attraction and sexual behaviors.51 Our study is cross-sectional in design and therefore, it 
permits us to report on possible associations but it is unable to determine causal relationships 
between smoking and sexual orientation. Further research with longitudinal studies is warranted. 
Finally, individuals may be reluctant to self-report being sexual minorities due to low supports, 
social stigma, fear of discrimination, social desirability, issues related to disclosure, or the 
private and personal nature of the question. Therefore, it is possible that the sexual minority 
population is under-reported in this study.  
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4.5 Conclusion 
Sexual orientation minority populations are diverse and highly vulnerable to smoking. The 
results of our study suggest that significant disparities in smoking exist within and between 
sexual minority and heterosexual populations. Additionally, bisexuals and lesbians/gays in 
Canada have different risk profiles for smoking and provide compelling evidence for designating 
the sexual minority community as a priority population for tobacco control, prevention and 
cessation efforts. To help reduce the burden of smoking among sexual minorities, family 
physicians, primary healthcare providers, policymakers and advocates need to use community-
based outreach strategies and implement interventions that are culturally sensitive, appropriate 
and tailored to meet the specific needs of this increasingly diverse community. 
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5. CHAPTER 5: EXAMINING THE PREVALENCE AND 
ASSOCIATION BETWEEN E-CIGARETTE USE AND CHRONIC 
OBSTRUCTIVE PULMONARY DISEASE IN CANADA: A CROSS-
SECTIONAL STUDY3 
1. Introduction: E-Cigarette use is a growing public health concern with 863,000 Canadian 
past 30-day users, defined as individuals who have used an e-cigarette in the past 30-days. 
While there are potential health consequences related to e-cigarettes, their use continues to 
grow. COPD is an irreversible lung condition characterized by limitation of the respiratory 
airways and systemic inflammation. Conventional tobacco use is the dominant cause of 
COPD. There are proposed mechanisms linking e-cigarette use to COPD. The purpose of this 
study was: 1) To determine the prevalence of e-cigarette use among COPD patients; 2) to 
determine the independent association between e-cigarette use and COPD status; 3) to 
determine the association between dual e-cigarette and conventional tobacco use on COPD 
and 4) to investigate the role of sex as an effect modifier. 
2. Methods: This study is a cross-sectional drawing data from the Canadian Community Health 
Survey (CCHS) 2015-2016. Weighted logistic regression analysis examined the relationship 
between e-cigarette use and self-reported COPD status and dual e-cigarette/conventional 
tobacco use and self-reported COPD while adjusting for other independent variables. 
3. Results: Individuals aged 35 years old or older (n=37,754) had an overall prevalence of 
COPD of 5.70%, while among past 30-day e-cigarette users, the prevalence increased to 
15.13%. The association of past 30-day e-cigarette use with COPD was statistically 
significant and modified by sex with females (aOR=3.00, 95% CI: 2.95-3.05) having a higher 
association than males (aOR=1.47, 95% CI: 1.43-1.50). Dual past 30-day e-cigarettes and 
current tobacco users were more likely to report COPD (aOR=14.16, 95% CI:13.91-14.42) 
compared to individuals using neither product. 
4. Conclusions: There is an independent association between e-cigarette use and COPD, which 
is modified by sex. Dual use of e-cigarette/conventional tobacco has a stronger association 
with COPD compared to either single product use.  
5. Keywords: E-cigarettes, tobacco smoking, COPD, Canada  
 
3 Mahmood R. et. al. Examining the prevalence and association between e-cigarette use and chronic obstructive 
pulmonary disease in Canada: A cross-sectional study. Manuscript under preparation for submission. 
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5.1 Introduction 
Electronic cigarettes (e-cigarettes) are battery-operated handheld electronic nicotine-delivery 
systems (ENDs). The vapor produced contains different flavorings, chemicals, nicotine 
concentration and is smokeless.1 Since their global introduction in 2006, there has been 
exponential growth and increasing popularity, especially among youth.2 Similar to strategies 
employed resulting in flavored tobacco becoming the preferable tobacco product among youth,3,4 
e-cigarettes have been marketed as safe, healthier than tobacco, and tobacco cessation devices 
designed to appeal as safe alternatives to conventional tobacco use.2,5  E-cigarettes have been 
marketed as a device that satisfies the need of nicotine for tobacco smokers while reducing or 
eliminating the disadvantages related to combustion and tar in tobacco smoke.6 However, studies 
on both tobacco smokers and e-cigarette users have found many differentially expressed proteins 
in airway epithelium tissue including proteins involved in immunomodulatory activities that 
contribute to respiratory disease pathogenesis.7,8 
The e-cigarette industry in 2018 was estimated to be worth $15.7 billion and continues to grow, 
and projected to be worth approximately $40 billion by 2023.9 In Canada, approximately 4.6 
million (15.4%) Canadians reported ever e-cigarette use, and 863,000 (2.9%) were classified as 
past 30-day e-cigarette users.10 Interestingly, tobacco users had the highest rate of e-cigarette use, 
with 54.1% of current smokers reporting ever use and 12.2% reporting past 30-day use, which 
might be more harmful, resulting in worse respiratory health outcomes.6,10 Additional Canadian 
trends show increased e-cigarette uptake and use among males, youth, and young adults and for 
tobacco cessation (23.6%), which might delay or prevent tobacco cessation entirely.6,10 Among 
US high school and middle school students, past 30-day e-cigarette users in 2018 had 
significantly increased compared to 2011, while past 30-day use of any tobacco product has not 
considerably changed during this period.11 This rise in the past 30-day use of e-cigarettes could 
be attributed to appealing characteristics of e-cigarettes such as more nicotine content, discrete 
and attractive shapes of the devices, and appealing flavorings.11 Moreover, there is cumulative 
evidence that e-cigarette use among youth is related to a higher risk of ever use of tobacco 
products.6 With the rapid growth in e-cigarette use and their relatively recent introduction, both 
short term and long-term health consequences are not fully understood. There is growing 
evidence of negative health outcomes, including cardiotoxicity,12,13 immune dysfunction,12 
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cerebrotoxicity,13 osteotoxicity,14,15 nicotine addiction,13,16 and mental health issues.17 Preclinical 
and clinical experiments have shown that e-cigarette use causes chronic pulmonary inflammation 
and suppressed immune response which is linked to negative respiratory health outcomes such as 
chronic obstructive pulmonary disease (COPD).13,18-20  
COPD is an irreversible lung condition, including both chronic bronchitis and emphysema. It is 
characterized by limitation of the respiratory airways and systemic inflammation with symptoms 
such as sputum production, chronic cough, and shortness of breath.21  This inflammatory 
response is strongly associated with cigarette smoking stress and only partially responds to anti-
inflammatory medicines, with smoking cessation improving prognosis.22 COPD has a global 
prevalence of 65 million and is predicted to become the third leading cause of death worldwide 
by 2030.23 The dominant cause of COPD is tobacco smoking.24 The pathogenesis of COPD 
through tobacco smoke inhalation is through multiple different mechanisms including increased 
lung inflammation, the protease/anti-protease theory, abnormal elastin synthesis, and repair, 
reactive oxygen species (ROS) mediated alveolar damage, epigenetic changes and through 
exposure to nicotine which acts on nicotinic-acetylcholine receptors.25-27 
Studies show women are more susceptible to developing COPD at younger ages possibly due to 
a faster annual decline in FEV1 percent compared to males, differences in genetics, levels of 
female sex hormones, cytokine expression, nicotine metabolism and the development of COPD 
symptoms at lower levels of tobacco exposure compared to males.24,28,29 Furthermore, evidence 
suggests that sex differences influence the clinical presentation of COPD, which was once 
considered a male dominant disease, with women being diagnosed at younger ages, having more 
morbidities, hospitalizations, and in-hospital deaths than men and often remaining undiagnosed 
due lack of proper evaluation.29,30 Since 2000, in the United States, the majority of deaths 
attributed to COPD are among females, with a continuing narrowing gap in the age-adjusted 
death rate between males and females.30 Environmental tobacco smoke exposure has been shown 
to be an independent, modifiable risk factor for COPD, both associated with its severity and 
incidence, possibly due to synergy with tobacco use and due to chronic inflammation and airway 
obstruction attributable to airway irritation from particulate matter in tobacco smoke, especially 
in homes.31-33 
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Studies examining the relationship between e-cigarette use and COPD have been conducted in 
vitro and in animal models finding that inhaled nicotine exposure using e-cigarette solutions 
affected cytokine expression, impaired mitophagy and increased lung cellular senescence, airway 
hyper-reactivity, lung tissue destruction, emphysema, impaired mucociliary clearance, increased 
risk of infections all potentially leading to the development of COPD34-38 potentially as toxic as 
tobacco exposure.39 Several human studies have been conducted to examine if a relationship 
between e-cigarette use and COPD exists. A population-based study suggested that an 
independent association between former and current e-cigarette use and COPD exists even when 
adjusting for smoking status with increased e-cigarette use (dose), leading to a stronger 
association with COPD.18,19,40 Moreover, additional findings point to dual users of e-cigarettes 
and tobacco having the strongest association with the development of the respiratory disease, 
higher nicotine dependence, and using more nicotine than conventional tobacco smokers.19,41   
Based on a literature review and the increasing trends in Canadian e-cigarette use, the objectives 
of this study are to: 1) to determine the prevalence of e-cigarette use among COPD patients; 2) to 
determine the association between e-cigarette use and COPD status; 3) to determine the 
association between dual e-cigarette and conventional tobacco use on COPD and 4) to 
investigate the role of sex as an effect modifier. 
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5.2 Methods 
5.2.1 Study design 
The data used in this study was from the Canadian Community Health Survey (CCHS) 2015-
2016 Public Use Microdata Files (PUMFs) data, made available to bona fide researchers through 
the Data Liberation Initiative (DLI) of Statistics Canada. It is anonymized survey data devoid of 
any personally identifying information. The secondary analysis of such data does not require 
ethical clearance. Participants in the original survey signed an informed consent and voluntarily 
participated in the survey. The original survey received ethical approval through Statistics 
Canada procedures. Cross-sectional studies allow the analysis of large samples to determine if an 
association exists between the exposure (e-cigarette use) and outcome (COPD status); however, 
causality cannot be inferred.42 As cross-sectional studies are relatively inexpensive and faster to 
conduct, they can provide background or exploratory results to inform future longitudinal studies 
incorporating cause and effect and temporality. 
The CCHS is an annual cross-sectional survey providing information on the health status, 
healthcare utilization, and health determinants of the Canadian population.43 The primary use for 
the CCHS is for health surveillance and population health research.43 The CCHS 2015-2016 
covers the Canadian population aged 12 years old and older, all ten provinces and three 
territories and excludes the following groups who represent approximately 3% of the Canadian 
population: individuals who live on reserves and other Aboriginal settlements in the provinces, 
full-time members of the Canadian armed forces, institutionalized individuals, children aged 12-
17 years old living in foster care and the Region du Nunavik and Region des Terres-Cries-de-la-
Baie-James health regions in Quebec.43 The CCHS is produced by the Health Statistics Division, 
Statistics Canada.43 
The CCHS samples the population using a multi-stage allocation strategy based on the 
population of each age group, province, and the health region within each province. There are 
two different frames used in sampling.43 Overall the response rate for the 2015-2016 CCHS was 
59.6% (185,176 selected, 110,095 responded).43 Survey weights were calculated and provided to 
increase generalizability from the sample to the general population.43 
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5.2.2 Study sample 
E-cigarette use was assessed as optional content in the 2015/2016 CCHS in Ontario, British 
Columbia, Nova Scotia and the Northwest Territories. Of the 109,659 participants surveyed, 
37,754 remained after excluding individuals not in the provinces surveyed on e-cigarette use, 
under the age of 35 years old, and due to missing data (COPD status, e-cigarette use, smoking 
status, age, sex, education, alcohol use and exposure to environmental tobacco smoke; 2.81%) 
(Figure 5.1).  
 
5.2.3 Outcome, primary independent and other independent variables 
The multiple tobacco products use theoretical framework44, and a literature review was used in 
identifying and selecting factors included in the analysis. This framework helps to better 
understand the influence of e-cigarettes compared to conventional tobacco smoking, and how 
they impact health outcomes such as COPD.44 
Total Sample (N=109,659)
Total in Ontario/British Columbia/Nova 
Scotia/Northwest Territories (n=53,078)
Total sample size (n=38,845)
Final analytic Sample (n=37,754)
Excluded due to missing data (n=1091)
Excluded under 35 years old (n=14,233)
Excluded due to provincial data (n=56,581)
Figure 5.1: Flow diagram showing the final analytic sample from CCHS 2015-2016. 
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The outcome variable for this study was self-reported COPD status (yes/no), representing the 
effect on health in the multiple tobacco product use framework. This question was administered 
to individuals aged 35 years old or older asking if the respondent has chronic bronchitis or 
emphysema or chronic obstructive pulmonary disease or COPD. 
The primary independent variable (product in multiple tobacco use framework) was past 30-day 
e-cigarette use (yes/no). Participants were asked if they used an electronic cigarette or e-cigarette 
in the past 30-days. 
Other independent variables related to COPD including person-level factors (age, sex and 
educational status (socioeconomic status indicator)), situational factors (alcohol consumption and 
exposure to environmental tobacco smoke), and products (tobacco cigarette use) were included. 
Age was recategorized as individuals aged 35-49 years old, 50-65 years old and 65 years or 
older. Sex was reported as biological sex (male or female). Educational status served as an 
indicator of socioeconomic status, with the highest level of education reported (Less than 
secondary school graduation or Secondary school graduation, no post-secondary education or 
Post-secondary certificate diploma or university degree). Alcohol use was assessed by self-
reported past 12-month type of drinker (regular drinker, occasional drinker, and did not drink in 
the last 12 months). Environmental tobacco smoke (ETS) exposure was assessed by asking if 
someone smokes inside the home every day (yes/no). Smoking status was recategorized into 
individuals who were current tobacco smokers (current daily smokers or current occasional 
smokers; individuals who smoked at least 100 cigarettes in their lifetime and smoked a cigarette 
in the past 30 days), former tobacco smokers (former daily smokers or former occasional 
smokers or experimental smokers who smoked at least one cigarette but not in the past 30 days) 
and never tobacco smokers (lifetime abstainer, never smoked a whole cigarette).  
To address the association between dual use of tobacco and e-cigarettes and COPD, we 
recategorized past 30-day e-cigarette use and smoking status into a dual use variable with the 
following levels: 1) Past 30-day e-cigarette and current tobacco user; 2) Past 30-day e-cigarette 
and former tobacco user; 3) Past 30-day e-cigarette and never tobacco user; 4) No past 30-day e-
cigarette use and current tobacco user; 5) No past 30-day e-cigarette use and former tobacco 
user; and 6) No past 30-day e-cigarette use and never tobacco user. 
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5.2.4 Statistical methods 
Descriptive statistics were calculated by examining the prevalence of COPD by each factor 
included in this study (past 30-day e-cigarette use, person-level factors, situational factors, and 
products). Past 30-day e-cigarette use by smoking status was examined to ascertain dual use, and 
both past 30-day e-cigarette and current tobacco use by age group to examine potential trends in 
use by age.  
In order to examine the association between COPD status and the past 30-day e-cigarette use, 
survey weights43 provided in the CCHS were applied to account for the sampling strategy and to 
improve generalizability of the results. The purposeful selection of covariates methodology was 
used.45 When determining the crude association (unadjusted) between the primary independent 
variable (past 30-day e-cigarette use) and the outcome variable (COPD status) as well as between 
the remaining independent variables and COPD status, an initial cut-off value p-value of 0.2546 
was used to assess if variables were to be kept in the final model. If the crude association was 
found to be significant (p-value ≤ 0.25), these variables were kept for multivariable logistic 
regression modeling. Models were developed using backward elimination with a p-value ≤ 0.05 
indicating statistical significance. As variables were removed, confounding was assessed by 
examining if the change in the regression coefficient of the primary independent variable 
changed by more than 20% (Δβ ≥ 20% indicated confounding). Variables that were not 
confounders were removed from the model. Multicollinearity was assessed using a variance 
inflation factor (VIF) of 2.5 as the cut of value, with values greater than 2.5, indicating 
multicollinearity.45 For the models using past 30-day e-cigarette use as the primary independent 
variable, all two-way multiplicative interactions were assessed using a p-value of 0.05. Model 
fitness was assessed using the Hosmer-Lemeshow goodness of fit test with a p-value ≥ 0.05, 
indicating the model is a good fit for the data.46 Data analysis was conducted using SAS 9.4. 
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5.3 Results 
5.3.1 Descriptive statistics 
The overall prevalence of COPD was 5.70% (n=37,754). Among past 30-day e-cigarette users, 
the prevalence of COPD was 15.13%. Dual users (past 30-day e-cigarette users and current 
tobacco users) had a prevalence of COPD of 14.74%. Individuals by the other independent 
variables with the highest prevalence of COPD were the oldest age group (8.62%), females 
(6.10%), the lowest level of educational attainment (10.72%), no past 12-month alcohol 
consumption (8.52%), exposure to environmental tobacco smoke (14.56%) and current smokers 
(11.28%) (Table 5.1). 
When examining the relationship between past 30-day e-cigarette use and tobacco smoking, the 
majority of past 30-day e-cigarette users were current tobacco users (70.38%) (Figure 5.2). The 
largest proportion of past 30-day e-cigarette users (n=800) were in the youngest age group (35-
49 years old), while current tobacco users (n=6543) had the highest proportion in the middle age 
group (50-65 years old). Magnitude wise there remained many more current tobacco users 
compared to past 30-day e-cigarette users (Figure 5.3). Among female past 30-day e-cigarette 
users, the prevalence of COPD was 19.95%, while males had a prevalence of COPD of 10.40% 
(past 30-day e-cigarette users, n=404) (Figure 5.4). When examining dual smoking behaviour, 
females had higher rates of COPD in all groups compared to males; past 30-day e-cigarette and 
current tobacco use (19.93%, n=281 vs. 9.57%, n=282), past 30-day e-cigarette and former 
tobacco use (20.72%, n=111 vs. 12.82%, n=117), no past 30-day e-cigarette use and current 
tobacco use (13.26%, n=2873 vs. 8.82%, n=3107), no past 30-day e-cigarette use and former 
tobacco use (6.48%, n=8919 vs. 5.56%, n=9004) and no past 30-day e-cigarette use and never 
tobacco use (2.59%, n=8407 vs. 1.68%, n=4644) (Figure 5.5). 
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Table 5.1: Descriptive statistics of Canadian cohort aged 35 years or older (n=37,754) 
Variable Level With 
COPD 
Without 
COPD 
Total 
(N) 
Primary independent variable 
Past 30-Day 
E-Cigarette use 
Yes 15.13% 84.88% 800 
No 5.49% 94.51% 36,954 
Dual e-cigarette and 
tobacco use 
Past 30-day e-cigarette user 
and current tobacco user 
14.74% 85.26% 563 
Past 30-day e-cigarette user 
and former tobacco user 
16.67% 83.33% 228 
Past 30-day e-cigarette user 
and never tobacco user 
0.00% 100% 9 
No past 30-day e-cigarette use 
and current tobacco user 
10.95% 89.05% 5980 
No past 30-day e-cigarette use 
and former tobacco user 
6.02% 93.98% 17,923 
No past 30-day e-cigarette use 
and never tobacco user 
2.27% 97.73% 13,051 
Person-Level Factors 
Age 35-49 1.92% 98.08% 9981 
50-65 5.29% 94.71% 13,071 
65 or older 8.62% 91.38% 14,702 
Sex Female 6.10% 93.90% 20,595 
Male 5.22% 94.78% 17,159 
Highest level of 
education 
Post-secondary certificate 
diploma or university degree 
4.32% 95.68% 23,303 
Secondary school graduation, 
no post-secondary education 
6.05% 93.95% 8647 
Less than secondary school 
graduation 
10.72% 89.28% 5804 
Situational Factors 
Past 12-month alcohol 
consumption 
Regular drinker 4.28% 95.72% 22,782 
Occasional drinker 6.99% 93.01% 6426 
Did not drink 8.52% 91.48% 8546 
Exposure to 
environmental tobacco 
smoke 
Yes 14.56% 85.44% 2727 
No 5.01% 94.99% 35,027 
Product Factor 
Smoking status Current 11.28% 88.72% 6543 
Former 6.15% 93.85% 18,151 
Never 2.27% 97.73% 13,060 
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Figure 5.2: Pie chart showing the proportion of e-cigarette users by tobacco smoking status. 
 
 
Figure 5.3: Bar chart depicting the proportion of past 30-day E-cigarette users and current 
tobacco smokers by age group. 
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Figure 5.4: Bar chart depicting the prevalence of COPD by e-cigarette use among females and 
males. 
 
Figure 5.5: Bar chart depicting the prevalence of COPD by dual smoking behaviour among 
females and males. 
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5.3.2 Logistic regression analysis 
The results of logistic regression analysis are detailed in Table 5.2. 
The first part of the study (Models 1-3, Table 5.2) used past 30-day e-cigarette use as the primary 
independent variable. Canadians aged 35 years old or older who were past 30-day e-cigarette 
users were 3.4 times more likely (95% CI: 2.49-4.61) to report COPD compared to non past 30-
day e-cigarette users (Model 1, crude association). A past 30-day e-cigarette and sex interaction 
term was significant (p-value < 0.05) in Model 2 and Model 3. When adjusted for age and 
smoking status (Model 2), the association between past 30-day e-cigarette use and COPD 
remained significant (Female aOR=2.96, 95% CI: 2.90-3.01; Male aOR=1.48, 95% CI: 1.45-
1.52) (Figure 5.6). In the final model (Model 3, adjusted for age, smoking status, education, 
alcohol and environmental tobacco smoke), past 30-day e-cigarette users were more likely to 
report COPD compared to no past-30 day e-cigarette users (Female aOR=3.00, 95% CI: 2.95-
3.05; Male aOR=1.47, 95% CI:1.43-1.50) (Figure 5.7). There was no evidence of 
multicollinearity (VIF ranged from 1.04-1.15) and the Hosmer Lemeshow test was used to assess 
model fit (p > 0.05). 
When examining dual use of e-cigarettes and tobacco (Models 4-6, Table 5.2), it is important to 
note that 9 individuals reported e-cigarette use and never tobacco use. This subgroup was 
removed from the analysis leaving 5 groups (past 30-day e-cigarette users and current tobacco 
users, past 30-day e-cigarette users and former tobacco users, no past 30-day e-cigarette users 
and current tobacco users, no past 30-day e-cigarette users and former tobacco users and no past 
30-day e-cigarette users and never tobacco users). The crude association between dual use and 
COPD status found that individuals who were both past 30-day e-cigarette and current tobacco 
users were 8.45 times more likely (95% CI: 5.63-12.66) to report having COPD compared to 
those with no past 30-day e-cigarette use and never tobacco smokers (Model 4). This association 
persisted when adjusting for age and sex in model 5 (aOR=13.65, 95% CI: 13.41-13.90) and in 
the final model (Model 6) when adjusting for age, sex, education, past 12 months alcohol use, 
and environmental tobacco smoke (aOR=14.16, 95% CI: 13.91-14.42).  
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Unlike models 1-3, there was not a statistically significant interaction between dual use and sex, 
however, females were more likely to report COPD compared to males in model 5 (aOR=1.54, 
95% CI: 1.53-1.55) and model 6 (aOR=1.45, 95% CI: 1.44-1.46). There was no evidence of 
multicollinearity (VIF ranged from 1.03-1.16) and the Hosmer Lemeshow test was used to assess 
model fit (p > 0.05). 
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Table 5.2: Logistic Regression Analysis: Association between smoking behaviour (e-cigarette 
and dual use) with COPD status  
 
Model  Primary independent variable Odds Ratio 
(95% CI) 
p-value 
Primary Independent Variable: Past 30-day e-cigarette use 
Model 11 
(Reference: No past 30-
day e-cigarette use) 
Past 30-day e-cigarette use 
 
3.39 
(2.49-4.61) 
< 0.0001 
Model 22 
(Reference: No past 30-
day e-cigarette use) 
Past 30-day e-
cigarette use | 
Sex Interaction 
Females 2.96 
(2.90-3.01) 
< 0.0001 
Males 1.48 
(1.45-1.52) 
Model 33 
(Reference: No past 30-
day e-cigarette use) 
Past 30-day e-
cigarette use | 
Sex Interaction 
Females 3.00 
(2.95-3.05) 
< 0.0001 
Males 1.47 
(1.43-1.50) 
Primary Independent Variable: Dual e-cigarette/tobacco use 
Model 44 
(Reference: No past 30-
day e-cigarette use and 
never tobacco smoker) 
Past 30-day e-cigarette user and current 
tobacco user 
8.45 
(8.30-8.60) 
< 0.0001 
Past 30-day e-cigarette user and former 
tobacco user 
9.64 
(9.42-9.87) 
< 0.0001 
No past 30-day e-cigarette use and current 
tobacco user 
6.50 
(6.44-6.56) 
< 0.0001 
No past 30-day e-cigarette use and former 
tobacco user 
2.73 
(2.70-2.75) 
< 0.0001 
Model 55 
(Reference: No past 30-
day e-cigarette use and 
never tobacco smoker) 
Past 30-day e-cigarette user and current 
tobacco user 
13.65 
(13.41-13.90) 
< 0.0001 
Past 30-day e-cigarette user and former 
tobacco user 
15.50 
(15.13-15.89) 
< 0.0001 
No past 30-day e-cigarette use and current 
tobacco user 
8.41 
(8.33-8.49) 
< 0.0001 
No past 30-day e-cigarette use and former 
tobacco user 
2.60 
(2.58-2.63) 
< 0.0001 
Model 66 
(Reference: No past 30-
day e-cigarette use and 
never tobacco smoker) 
Past 30-day e-cigarette user and current 
tobacco user 
14.16 
(13.91-14.42) 
< 0.0001 
Past 30-day e-cigarette user and former 
tobacco user 
16.83 
(16.41-17.25) 
< 0.0001 
No past 30-day e-cigarette use and current 
tobacco user 
8.55 
(8.47-8.64) 
< 0.0001 
No past 30-day e-cigarette use and former 
tobacco user 
2.96 
(2.93-2.99) 
< 0.0001 
1Crude association between past 30-day e-cigarette use and COPD 
2Past 30-day e-cigarette use*Sex interaction term and COPD (adjusted for age, and smoking status) reporting interaction 
term. 
3Past 30-day e-cigarette use*Sex interaction term and COPD (adjusted for age, smoking status, education, alcohol, 
environmental tobacco smoke). 
4Crude association between dual use (past 30-day e-cigarette and tobacco smoking) on COPD. 
5Dual use and COPD (adjusted for age and sex) 
6Dual use and COPD (adjusted for age, sex, education, alcohol, environmental tobacco smoke)
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Figure 5.6: Interaction plot from Model 2 showing the association (adjusted odds ratio; aOR) 
between COPD status and the interaction between sex (female or male) and past 30-day e-
cigarette use adjusted for age and smoking status. 
 
 
Figure 5.7: Interaction plot from Model 3 showing the association (aOR) between COPD status 
and the interaction between sex (female or male) and past 30-day e-cigarette use adjusted for 
age, smoking status, education, alcohol use and environmental tobacco smoke. 
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5.4 Discussion 
This study is used Canadian data from Ontario, British Columbia, Nova Scotia and the 
Northwest Territories to examine the association between e-cigarette use and COPD. The overall 
prevalence of COPD in our sample of Canadians aged 35 years old and older was 5.70%, with 
past 30-day e-cigarette users having an almost three-fold increase, and dual users reporting an 
even higher prevalence of COPD (Table 5.1 and Figure 5.3).  Our results indicate that past 30-
day e-cigarette use among Canadians was independently associated with COPD, with dual users 
having higher odds of reporting COPD, which support findings from previous studies.18,19,47,48 
Furthermore, we identified an effect modification by sex (Table 2), which has not previously 
been reported and has potential ramifications due to sexual dimorphisms in nicotine metabolism, 
addiction, and the onset of negative health consequences such as COPD. 
We found a higher prevalence of COPD among females compared to males and a stronger 
association between e-cigarette use and COPD among females (Table 5.1, Table 5.2). Previous 
studies reported similar results with the prevalence of COPD being higher among females 
compared to males.18,19,48 However, they did not examine the association between e-cigarette use 
and sex on COPD status. In addition, contrary to existing literature, we found the female to male 
ratio of past 30-day e-cigarette users to be approximately 1:1 (n=396 females; n=404 males), 
with the ratio remaining similar between sexes for dual use. Sex-based differences in the onset of 
COPD as a result of tobacco use has been well characterized and discussed in the introduction 
with different mechanisms proposed (genetics, female sex hormone levels, cytokine expression, 
nicotine metabolism, and lower threshold of exposure).24,28-30 As e-cigarettes are a type of 
electronic nicotine delivery system, it is reasonable to assume some crossover in the 
pathogenesis of COPD between e-cigarette and conventional tobacco use hence, resulting in 
similar outcomes in females when compared to males. Our findings are relevant as e-cigarette 
use leads to nicotine dependence,13,16 with one study concluding that quitting e-cigarettes was 
more difficult than conventional tobacco49 however, there is a lack of consensus on the matter as 
other studies have suggested e-cigarettes do not have the addictive potential of conventional 
tobacco cigarettes,50,51 requiring more research. Irrespective of the magnitude of addiction, 
nicotine is known to be addictive, and females may be more responsive to social influences and 
vulnerable to targeted marketing especially those incorporating self-image, weight control and 
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health.50 Females have quicker nicotine and cotinine metabolism due to estrogen, which worsens 
cessation efforts in tobacco research,51 and develop symptoms of COPD at lower levels of 
tobacco exposure compared to males.24,28,29 One study examining US e-cigarette sales found the 
majority of e-cigarette sales between 2013-2018 were for nicotine containing products, and non-
nicotine products accounted for less than 1% of the market share.52 While data from the 2017 
Canadian Tobacco, Alcohol and Drugs survey (CTADS) found most ever e-cigarette users 
surveyed (78.9% of males and 70.1% of females) used nicotine the last time they vaped10 further 
illustrating that it is essential to investigate and inform of potential deleterious effects of e-
cigarettes such as COPD and to account for potential sex-based differences.  
Dual use of conventional tobacco and e-cigarettes is an emerging public health concern. This 
study found the majority of past 30-day e-cigarette users were also current (past 30-day) tobacco 
users and had a stronger association with COPD compared to current tobacco only users. Due to 
sampling limitations, we were unable to assess the association between past 30-day e-cigarette 
use and COPD among never tobacco users, though, previous studies identified an association 
exists.40,47,48 In previous studies, the majority of conventional smokers reported using e-cigarettes 
to aid in tobacco cessation, harm reduction and for its taste.53,54 There is a lack of consensus in 
the published literature of the efficacy of e-cigarettes as tobacco cessation devices with a recent 
systematic review and meta-analysis concluding that individuals using e-cigarettes had 28% 
lower odds of quitting conventional tobacco cigarettes compared to non e-cigarette users.55 
Furthermore, dual use with e-cigarettes may circumvent existing smoke-free policies which are 
shown to motivate and support tobacco cessation,54 reduce individuals perceptions to quit56, and 
increase the dosage of nicotine throughout the day, thus inhibiting smoking cessation by 
increasing nicotine addiction. The latter was shown in a study conducted in France, which found 
that dual users were exposed to more nicotine throughout the day compared to only e-cigarette 
users; however, they did not compare their results with conventional tobacco use.57 Our results 
showed that a significant proportion of past 30-day e-cigarette users were former conventional 
tobacco smokers. As our results are cross-sectional, it is not possible to ascertain whether e-
cigarette use, or COPD occurred initially. Therefore, “switching” from conventional tobacco use 
to e-cigarette use as a harm reduction strategy may influence the strength of the association 
between dual use and COPD. There is evidence indicating that current or former conventional 
tobacco smokers with COPD are more likely to try e-cigarettes compared to conventional 
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tobacco smokers without COPD58 for tobacco cessation or reduction. However, this change in 
nicotine product may prevent conventional tobacco smoking or it may lead to re-uptake of 
tobacco cigarettes as e-cigarettes do not replicate the conventional tobacco experience.56 A 
longitudinal study in the USA found that former tobacco smokers who used e-cigarettes to quit 
smoking were more likely to relapse.59 In contrast, those who used e-cigarettes due to the flavors 
and smells were less likely to return to conventional tobacco smoking.59 The potential for 
additive or synergistic health outcomes due to dual e-cigarette and conventional tobacco use on 
the severity of COPD requires additional research. An American cross-sectional study using the 
Heart eHealth Study found dual users compared to conventional tobacco users exhibited worse 
median general health scores and breathing scores, including COPD.60 While an observational 
study concluded that dual users were more nicotine dependent, inhaling more nicotine compared 
to conventional tobacco only smokers, found no statistically significant difference in the number 
of tobacco cigarettes smoked and found no evidence supporting using e-cigarettes as a harm 
reduction strategy among current smokers.41 In contrast to this result, an Italian retrospective 
cohort study (n=44) with a three year follow up compared the exacerbation rate of COPD 
between dual users, e-cigarette only users and single users of tobacco.61 They observed a 
significant reduction in COPD exacerbation rate among e-cigarette only and dual users but no 
significant change among tobacco smokers.61 Additionally, they reported complete tobacco 
cessation in around 60% of the dual users by the third follow up visit, and a significant reduction 
in cigarettes smoked in 40% of the remaining dual users.61 Therefore, the reduction in COPD 
exacerbation rates could be attributed to tobacco reduction or cessation but there was no 
improvement in lung function attributable to switching to e-cigarettes or dual use. The lack of 
consensus in the literature regarding e-cigarettes as harm reduction devices for COPD patients 
warrant further study to elucidate their therapeutic potential. 
Study’s strengths and limitations 
This study had several strengths, including a large sample size using Canadian data to examine 
the association between e-cigarettes and COPD, and the dual use of e-cigarettes and conventional 
tobacco with COPD. We identified biological sex as an effects modifier in this association in our 
analysis, which has not been previously reported but is plausible based on previous research into 
COPD. However, due to societal and environmental factors influencing COPD we were unable 
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to examine gender differences or disentangle sex and gender-based differences. As our study is 
cross-sectional, we are unable to infer causality as we do not have a temporal component, we can 
only report potential association. It is possible individuals with COPD started using e-cigarettes 
or vice-versa. However, our findings are consistent with previous research. Furthermore, due to 
sample size limitations, we were unable to assess the association between past 30-day e-cigarette 
use among never conventional tobacco smokers with COPD. Another limitation of this study is 
the inability to assess nicotine levels and exposure frequency to e-cigarettes. As this was an 
exploratory, cross-sectional study, it is important to note that COPD is a chronic disease taking 
years to develop, e-cigarettes on the other hand a relatively new product, therefore this may have 
affected our estimates and limited the data available to us. The CCHS uses a complex sampling 
procedure to provide reliable health region level estimates but there is potentially an issue due to 
clustering, however we incorporated the weights provided in our analysis to better represent the 
population under study. There is a need to develop validated, comprehensive methods to assess 
e-cigarette usage similar to conventional tobacco smoking (pack years, classification such as 
never smokers, experimental smokers, former smokers, occasional, daily and current smokers) 
examining nicotine content, type of device and the dosage and frequency of exposure to improve 
estimates. Finally, our e-cigarette variable was past 30-day e-cigarette use, a binary yes or no 
question. As such, ever users of e-cigarettes who did not use e-cigarettes in the past 30-days 
would respond no. This may result in over or under-estimation of the association between e-
cigarette use and COPD. However, previous studies have indicated that ever e-cigarette use is 
associated with future current tobacco use, potentially leading to COPD.62-67 Future studies 
should incorporate past 30-day, ever and never e-cigarette use where possible. 
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5.5 Conclusion 
This study uses Canadian data from three provinces and one territory, examining the association 
between e-cigarettes and dual tobacco and e-cigarette use and COPD. Our findings indicate that 
there is an independent association between e-cigarette use and COPD that is more pronounced 
among females but is also present in males. While the majority of tobacco smokers who use e-
cigarettes report it is for tobacco cessation, the majority of past 30-day e-cigarette users were 
dual users. Increased efforts need to be made in policy and health promotion campaigns to better 
inform individuals on the risks associated with e-cigarette use as current norms and beliefs have 
been shaped by e-cigarette marketing strategies and individuals are not aware of the potential 
harms related to e-cigarette use. Further longitudinal studies are required to assess whether e-
cigarette use among never conventional tobacco smokers can lead to the development of COPD 
and whether e-cigarette use among COPD patients can lead to a decrease in the severity of the 
disease.  
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6. CHAPTER 6: E-CIGARETTES AS TOBACCO INITIATION DEVICES: 
A SYSTEMATIC REVIEW AND META-ANALYSIS4 
Introduction: E-cigarettes are electronic nicotine delivery systems being rapidly adapted by 
youth as conventional tobacco initiation decreases, partially attributed to effective policies and 
initiatives. The gateway hypothesis posits that e-cigarettes can lead to tobacco initiation. The 
purpose of this study is to examine if e-cigarette use among naïve nicotine users leads to 
conventional tobacco use over time. 
Methods: The following databases were searched: PubMed, Ovid MEDLINE, Public Health 
Database, Scopus and Cochrane Library. Inclusion criteria included: 1) human participants; 2) 
open access, peer-reviewed English language studies published between 2010-2019; 5) 
longitudinal studies; 6) baseline never smokers; 7) baseline e-cigarette use assessed; 8) 
conventional tobacco initiation assessed at follow-up; and 9) control group of nicotine naïve 
participants (never e-cigarette and conventional tobacco users). Risk of bias was assessed within 
and between studies. Random effects models were used for meta-analysis. 
Results: Out of the 3412 articles identified, 17 were used in quantitative synthesis (meta-
analysis); 16 of the 17 examined the association of ever e-cigarette use at baseline and tobacco 
initiation at follow up and 7 or the 17 examined the association of ever e-cigarette use at baseline 
and current tobacco use at follow up. Ever e-cigarettes users were aOR=3.28 times more likely 
(95% CI: 2.74-3.92; I2=62.91) to initiate conventional tobacco smoking at follow-up and 
aOR=1.89 (95% CI: 1.34-2.66; Q=28.43) times more likely to be current tobacco smokers at 
follow up. 
Conclusions: This study provides up to date data showing that e-cigarette use is associated with 
tobacco initiation over time, providing up to date evidence to public health professionals and 
policymakers based on longitudinal studies that can inform planning, evaluation and 
implementation of comprehensive tobacco prevention and control programs. 
Keywords: E-cigarettes, tobacco smoking, initiation, gateway hypothesis 
 
4 Mahmood R. et. al. E-cigarettes as tobacco initiation devices: A systematic review and meta-analysis. Manuscript 
under preparation for submission. 
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6.1 Introduction 
The e-cigarette is modern battery-powered electronic nicotine delivery system (ENDS) which 
functions by vaporizing a liquid solution (e-liquid) containing nicotine (can be no nicotine to 
higher levels), flavours, and other additives (i.e. propylene glycol and vegetable glycerin).1,2 E-
cigarettes have different designs, generations and appearance but are similar in operation and 
consist of common components such as an e-liquid containing cartridge and an atomizer to heat 
the e-liquid.1 Once the e-liquid is heated sufficiently to create an aerosolized vapour the user 
inhales the vapour through the mouthpiece.1 The aerosols give the users a somewhat similar 
experience to conventional tobacco smoking although former smokers may feel that e-cigarettes 
are not necessarily reflective of the conventional tobacco smoking lived experience.3 E-cigarettes 
were developed by a Chinese pharmacist in 2003, patented internationally in 2007 and have 
since been increasingly adopted globally.2 
E-cigarette uptake has rapidly risen, especially among youth and young adults. In the United 
States of America between 2011-2018, past 30-day e-cigarette use has risen from 1.5% to 20.8% 
among high school students.4 In response to the explosive growth of e-cigarette use, surpassing 
even conventional tobacco cigarette use in 2014 among youth, the US Surgeon General 
concluded that e-cigarette use is a significant public health concern.1 In Canada, e-cigarette 
uptake has not been as pronounced as in the USA with the Canadian Student Tobacco, Alcohol 
and Drugs Survey (CSTADS) reporting the prevalence of past 30-day e-cigarette use among 
students in grades 7-12 to have risen from 6.5% in 2014/15 to 10.0% in 2016/17.5 Concurrently 
with the rise in e-cigarette use, there has been an overall decline in conventional tobacco use in 
Canada, however, there was a statistically significant increase in past 30-day tobacco use from 
13% (2015) to 15% (2017).6 
Annual e-cigarette sales in the United states have grown rapidly from a modest $76 million USD 
in 2011 to approximately $1.3 billion USD in 2017.7 There are different modalities contributing 
to e-cigarette uptake including successful targeted advertising campaigns through digital 
marketing, social media, television, radio, print and retail establishments,8,9 acceptability,10-12 
easy accessibility,13,14 perceived safety,9,11-13,15-17 aesthetically pleasing,12,13,16,18 perceptions of 
lack of addictivity,19 perceptions of being a tobacco cessation device,15,17 varied flavours 
appealing to youth and adults16,12 and currently being in vogue leading to societal pressure.9,16,18  
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The rise in e-cigarette use raises concerns regarding long-term public health consequences. Due 
to the relatively recent introduction of e-cigarettes and the rapid uptake, studies examining health 
consequences are lagging with a lot of unknown and uncharacterized direct health effects and 
indirect effects such as consequences of nicotine addiction and the potential for e-cigarettes to be 
a gateway to future tobacco initiation. Proponents of e-cigarettes suggest that it can be used as a 
harm reduction device leading to a reduction in conventional smoking20-24 however, there is a 
lack of consensus with other studies suggesting e-cigarettes are not an effective tobacco 
cessation device, and might make tobacco cessation more difficult.25-27 Moreover, there is a 
growing body of evidence that has shown there is an association between e-cigarette use and 
subsequent smoking initiation among never-smoking adolescents and young adults. Results from 
several early cross-sectional studies found an association between e-cigarette use and 
conventional tobacco initiation.28 However, these findings were limited as several confounding 
factors, including age groups and geographic location were not considered.28 Furthermore, a 
recent longitudinal study had similar results (e-cigarette use leads to tobacco initiation) and they 
assessed this association using validated tobacco initiation susceptibility measures, classifying 
never smokers as susceptible (high risk) and non-susceptible (low risk) to tobacco use, with 
baseline e-cigarette users in both groups having higher odds of initiation compared to non e-
cigarette users.29  
The gateway hypothesis was initially used when examining if conventional tobacco use led to 
illegal drugs, this has since been applied to the relationship between tobacco naïve individuals 
who initially start using e-cigarettes and eventually start conventional tobacco use.30 Two major 
criticisms of this hypothesis are there is no causal explanation of why tobacco and e-cigarette 
naïve individuals start with e-cigarettes rather than conventional tobacco and why e-cigarette 
users eventually transition to conventional tobacco use or dual use.30 To address the first 
criticism, the flavour, health, role model, concealment and acceptance hypotheses have been 
proposed to explain why tobacco and e-cigarette naïve individuals are more likely to start with e-
cigarettes compared to conventional tobacco, while the addiction, accessibility and experience 
hypotheses address the latter criticism.30 A simpler argument against the gateway hypothesis is 
that while e-cigarette use is increasing among youth, why are tobacco rates decreasing.31 While 
lower tobacco use among youth is a trend seen in many countries, making the aforementioned 
assumption is applying aggregate population level observations to individuals; the ecological 
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fallacy and only well designed prospective cohort or randomized clinical trials can truly assess 
the gateway hypothesis.31 
After examining the literature it is clear there is a lack of consensus on the gateway hypothesis, 
but there is proposed relationship between e-cigarette use and tobacco initiation which may 
negatively impact effective tobacco control policies and societal and community efforts to reduce 
the incidence and prevalence of tobacco use, thus, reducing the associated morbidity and 
mortality associated with tobacco use. This could lead to a delayed onset neo-tobacco epidemic 
if not appropriately investigated. The purpose of this study was to 1. Determine if e-cigarette use 
increases the risk of conventional tobacco initiation among a cohort of never conventional 
tobacco users; 2. Examine whether different e-cigarette use behaviors (past 30-day, ever use) 
affect conventional tobacco use; and 3. Evaluate what if any sex differences exist in conventional 
tobacco initiation after e-cigarette use. 
  
118 
 
6.2 Materials and Methods 
6.2.1 Eligibility criteria 
Studies that were eligible included study participants of any age that were never conventional 
tobacco smokers at the start of the study (population). These studies assessed e-cigarette use in 
the study population (intervention), included non-e-cigarette users and never conventional 
tobacco smokers as the control group (comparator) and measured conventional tobacco initiation 
(outcome). English language, peer-reviewed, open access, longitudinal prospective or 
randomized cluster studies published since 2010 were included in this study.  
6.2.2 Information sources 
Studies were identified through searching electronic databases and snowballing from reference 
lists of the included studies. This search was applied to the PubMed, MEDLINE: Ovid 
MEDLINE, Public Health Database, Scopus and Cochrane Library databases. The last search 
was run on February 3rd, 2020.  
6.2.3 Search 
Our search strategy included using medical subject headings and keywords applied to the 
databases searched as appropriate. The search strategy was arranged by e-cigarette use and 
conventional tobacco smoking initiation. The PubMed search used in this study was the 
following: ((("electronic cigarettes") OR "e cigarettes")) AND (((("initiation") OR "smoking 
initiation") OR "gateway") OR "tobacco use") 
6.2.4 Study selection 
Articles included were screened in two steps: 1) title and abstract screening and 2) full-text 
screening. Initial calibration was conducted by two authors using 20 randomly selected articles. 
Results were compared and discussed with the third author, after which eligibility criteria were 
refined followed by dual independent screening. In the case of disagreement after screening (title 
and abstract or full-text screening), the two authors would discuss the article among themselves 
and in cases where consensus was not achieved, a third author would provide the tie-breaker 
vote. Articles which satisfied the following criteria were included: 1) human participants, 2) 
published between 2010-2020, 3) English language, 4) open access or accessible through the 
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University of Saskatchewan Library, peer-reviewed articles, 5) longitudinal studies, 6) initial 
population of never smokers quantified at baseline, 7) quantified e-cigarette use among cohort at 
baseline, 8) quantified conventional tobacco initiation at follow-up, 9) had a control group of 
nicotine naïve participants (never e-cigarette and conventional tobacco users). 
6.2.5 Data collection and items 
Data extraction used Microsoft Excel sheets developed by the authors of the study and dual 
extraction was employed. After completing data extraction, the two authors compared results 
with a third providing a tie-breaker vote in case of disagreement. Information extracted from the 
included articles included: authors, year of publication, study design, the name of the study 
cohort (when applicable), type of intervention (school based or population based), country of the 
study, years the study was ongoing, follow up time in years, overall sample size, the age (mean, 
median or range) or grade of the population, definition of the intervention (ever e-cigarette use or 
past 30-day e-cigarette use), definition of the control group (never e-cigarette user, never 
conventional tobacco smoker or no past 30-day e-cigarette use, never conventional tobacco 
smoker), the sample size of the intervention and control group, type of outcome variable 
(tobacco initiation and current tobacco user) and quantitative data of the outcome variable (odds 
ratio, 95% confidence interval and risk ratio, 95% confidence interval). If multiple outcomes 
were presented, the most adjusted values were extracted to provide the most conservative 
estimates. 
6.2.6 Risk of bias in individual studies 
A modified Newcastle Ottawa Scale (NOS) for cohort studies32 was used to assess the risk of 
bias. Two authors independently assessed bias in the selection, comparability and outcome of 
each study, after which results were compared. The authors discussed any disagreement and in 
cases where consensus was not reached a tiebreaker was provided by the third author (See 
Appendix 1 for modified NOS Scale and grading). 
6.2.7 Summary measures and synthesis of results 
The majority of articles assessing tobacco initiation reported odds ratio (OR) and 95% 
confidence intervals (95% CI) as the outcome measure over time. Hence, the meta-analysis was 
conducted by computing and/or incorporating the odds ratio from the studies included using 
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random effects models. Random effects models were used to provide conservative estimates of 
the pooled data, with wider confidence intervals compared to fixed effects models.33 
Furthermore, while the fixed effects model assumes the true effect size is the same in all studies, 
the random effects model is more appropriate for this study as it assumes the summary measure 
varies from study to study and the result is the mean of these effects34 and it accounts for both 
within-study and between-study variability.35 The I2 statistic describes the total variation between 
studies due to heterogeneity rather than chance and is calculated as I2=100%*(Q-df)/Q; where Q 
is the Cochrane heterogeneity statistic and df is degrees of freedom.36 Broadly, I2 can be 
categorized as low (25%), moderate (50%) and high (75%), though the methodological and 
clinical implications of potential heterogeneity should be accounted for when conducting a meta-
analysis.36 Studies were combined based on baseline ever e-cigarette use (and never conventional 
tobacco smokers) and at follow-up both tobacco initiation (first time smokers, not necessarily 
past 30-day tobacco smokers) and current tobacco smokers (individuals who smoked 
conventional tobacco cigarettes over the past 30-days who were new tobacco initiators). 
6.2.8 Risk of bias across studies 
In order to assess how risk of selection bias might affect the results of the meta-analysis, 
publication bias was assessed using both funnel plots and Egger’s test. The funnel plot has the 
standard error on the y-axis and log odds ratio on the x-axis. More precise estimates of the 
intervention effect appear higher on the funnel plot while smaller less precise estimates scatter at 
the bottom of the plot. If they are symmetrical it suggests an absence of bias, but if there is a 
skew or asymmetry it suggests potential publication bias.37 Furthermore, Egger’s test, a form of 
linear regression of the normalized effect estimate against precision was used to confirm the 
presence of potential publication bias.37 
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6.2.9 Additional analysis 
In cases where publication bias was detected, the Duval and Tweedie’s trim and fill was 
conducted to correct funnel plot asymmetry. This non-parametric methodology is a simple 
estimation approach where the asymmetric outlying part of the funnel is trimmed, the symmetric 
remainder is used to estimate the centre of the funnel and the trimmed studies and their missing 
counterparts are returned (filled).38 Due to the differences in follow-up time between studies, 
subgroup analysis was conducted to examine whether outcomes differed between studies based 
on follow-up time. We were unable to assess past 30-day e-cigarette use or sex-based differences 
in e-cigarette use and tobacco initiation as there were insufficient studies examining past 30-day 
e-cigarette use and no studies stratifying conventional tobacco initiation by sex. 
6.3 Results 
6.3.1 Study selection 
In total, 3412 studies were identified through the database searches. After removing duplicates 
(n=1172), 2240 studies remained for title and abstract screening of which 2143 were excluded 
according to the eligibility criteria. After full-text screening (n=97), 73 articles were excluded 
with 24 articles remaining for qualitative synthesis28,29,39-60 and 17 articles for quantitative 
synthesis (meta-analysis).28,39-44,46,48,49,51,54-57,59,60 Studies excluded from meta-analysis was due 
to: 1) Did not assess baseline ever e-cigarette use, just past 30-day e-cigarette use;29,45,52 2) Did 
not provide the follow-up time;47 3) Outcome was risk ratios;50,53 and 4) Assessed baseline e-
cigarette use by nicotine vs. no nicotine content.58 
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Figure 6.1: PRISMA Flow Diagram detailing study selection 
Records identified through database 
searching
n=3412 
Title and abstract screening
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n=7
Full-text articles excluded
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Duplicates removed
n=1172
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6.3.2 Study characteristics 
There were 24 final articles included in this study for qualitative synthesis. Characteristics of the 
studies from which data was extracted included longitudinal studies, either prospective cohort 
studies or prospective cluster randomized studies. The studies were published between 2015-
2019 with the range of data collection from 2012-2016. The follow-up period of the 
interventions was between six months to two years. Studies included were from the United States 
of America (n=13), Canada (n=2), Mexico (n=1), United Kingdom (n=3), Germany (n=1), 
Netherlands (n=1), Finland (n=1), Romania (n=1) and China (n=1). Participants ranged from 
youth aged 11-13 years old to adults aged 35 and older based on the study. The majority of the 
studies assessed ever e-cigarette use as the intervention group with never e-cigarette and 
conventional tobacco smoking as the control group at baseline. The outcome of interest in the 
studies was either the initiation (ever use) of conventional tobacco smoking or current (past 30-
day) conventional tobacco smoking at follow-up (Table 6.1).
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Table 6.1: Summary of included study characteristics  
 
Source Study Design 
and Setting 
Name of 
Study 
Country Follow up 
time 
(years) 
and years 
of study 
Sample 
size 
 
Factor under 
study 
 
Control 
 
Outcome 
variable 
 
Outcome 
value 
Covariables adjusted 
for in models 
(outcome value) 
Aleyan, 
201829 
Prospective 
Cohort 
School-based 
COMPASS Canada 2 
 
2013/14-
2015/16 
9501 Past 30-day e-
cigarette use 
(Baseline) 
No Past 30-
day E-
Cigarette use, 
never smokers 
by smoking 
susceptibility 
Tobacco 
initiation 
(Susceptible) 
OR: 2.78 
(95% CI: 
1.84-
4.20) 
Sex, grade, ethnicity, 
friends who smoke 
cigarettes at baseline, 
weekly spending 
money, school Tobacco 
initiation 
(non-
susceptible) 
OR: 5.28 
(95% CI: 
2.81-
9.94) 
Barrington, 
201628 
Prospective 
Cohort 
School-based 
Children’s 
health Study 
USA 1.5 
 
2014-2016 
298 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
OR: 4.29  
(95% CI: 
1.84-
10.0) 
sex, ethnicity, grade, 
parental education 
Barrington, 
201839 
Prospective 
Cohort 
School-based 
Children’s 
health Study 
 
Happiness & 
Health Study 
 
Yale 
Adolescent 
Survey Study 
USA 1 
 
2013-2016 
6258 Ever e-cigarette 
use (baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation  
 
OR: 4.57  
(95% CI: 
3.56-
5.87) 
 
sex, ethnicity, grade, 
study group 
Current 
tobacco 
smoker 
 
OR: 3.51  
(95% CI: 
1.97-
6.24) 
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Berry, 201940 Prospective 
Cohort 
Population 
based 
Population 
Assessment of 
Tobacco and 
Health Study 
(PATH) 
USA 2 
 
2013-2016 
6123 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
 
OR: 4.09  
(95% CI: 
2.97-
5.63), 
 
sex, age, ethnicity, 
parental education, 
urban/rural, living with 
tobacco user, noticing 
tobacco warnings, 
tobacco advertisement 
receptivity, nine 
measures of 
susceptibility/risk 
Current 
tobacco 
smoker 
 
OR: 2.75  
(95% CI: 
1.60-
4.73) 
Chien, 201941 Prospective 
Cohort 
School-based 
Taiwan 
Adolescent to 
Adult 
Longitudinal 
Study 
(TAALS) 
Taiwan/Ch
ina 
2 
 
2014-2016 
12954 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
OR: 2.14  
(95% CI: 
1.66-
2.75) 
smoking susceptibility, 
father's education, 
mother's ethnicity, 
socioeconomic status, 
age, peer support 
Conner, 
201842 
Cluster-based 
randomized 
control trial 
School-based 
Study 
reference 12–
0155 (Faculty 
of Medicine, 
Leeds) 
UK 1 
 
2014-2015 
1726 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
OR: 4.06  
(95% CI: 
2.94-
5.60) 
friend smokers, sex, 
family smokers, 
intentions, attitudes, 
norms, perceived 
behavioural control, 
self-efficacy, free 
school meals 
Conner, 
201943 
Cluster-based 
randomized 
control trial 
School-based 
Study 
reference 12–
0155 (Faculty 
of Medicine, 
Leeds) 
UK 2 
 
2014-2016 
 
3994 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
 
OR: 2.78  
(95% CI: 
2.20-
3.51) 
 
Sex, ethnicity, SES, 
free school meals, 
friend smokers, family 
smokers, impulsivity, 
intentions, attitude, 
perceived norms, 
perceived behavioural 
control, self-efficacy 
Current 
tobacco 
smoker 
 
OR: 1.27  
(95% CI: 
1.17-
1.39) 
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East, 201844 Prospective 
Cohort 
Population-
based 
2016 Action 
on Smoking 
and Health 
Great Britain 
Youth 
longitudinal 
survey 
UK 0.5 
 
2016 
923 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
OR: 
10.57  
(95% CI: 
3.33-
33.50) 
Age, sex, school 
performance, 
problematic 
behaviours, alcohol 
use, smoking 
susceptibility, friends 
who smoke friends 
who vape, parents who 
smoke, parents who 
vape, sibling smokers, 
sibling vapers, public 
approve of smoking, 
public approve of e-
cigarettes 
Hammond, 
201745 
Prospective 
Cohort 
School-based 
COMPASS Canada 1 
 
2013/14-
2014/15 
17318 Past 30-day e-
cigarette use 
(Baseline) 
No Past 30-
day E-
Cigarette use, 
never smokers 
Tobacco 
initiation 
 
OR: 2.12 
(95% CI: 
1.28-
1.62) 
Age, sex, ethnicity, 
spending money, 
smoking status 
Kinnunen, 
201946 
Prospective 
Cohort 
School-based 
Metropolitan 
Longitudinal 
Finland 
Finland 2 
 
2014-2016 
1923 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Current 
tobacco 
smoker 
OR: 2.92  
(95% CI: 
1.09-
7.85) 
Sex, Parent's education 
(SES), Other tobacco 
use 
Kintz, 201947 Prospective 
Cohort 
School-based 
Children’s 
Health Survey 
USA 0.5-1 
 
2014-2016 
1293 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
OR: 4.91 
(95% CI: 
3.42-
7.05) 
Unadjusted, crude OR 
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Leventhal, 
201548 
Prospective 
Cohort 
School-based 
 USA 0.5 
 
2013-2014 
2530 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
OR: 1.75  
(95% CI: 
1.10-
2.77) 
Age, sex, ethnicity, 
parental education, 
family structure, family 
smoking, peer 
smoking, mental health 
disorders, smoking 
susceptibility 
Loukas, 
201849 
Prospective 
Cohort 
College-based 
Marketing and 
Promotions 
across 
Colleges in 
Texas project 
USA 1.5 
 
2014-2016 
2558 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation 
OR: 2.26  
(95% CI: 
1.35-
3.76) 
Sex, age, ethnicity, 
school type, cigarette 
use susceptibility, 
family tobacco use, 
friend tobacco use, 
Lozano, 
201750 
Prospective 
Cohort 
School-based 
 Mexico 1.67 
 
2015-2016 
4695 Ever e-cigarette 
use (Baseline) 
Never e-
cigarette, 
never tobacco 
users 
Tobacco 
initiation  
 
aRR: 
1.40  
(95% CI: 
1.22-
1.60) 
 
sex, age, parent SES, 
sensation seeking, 
friends that smoke, 
parents that smoke, 
siblings that smoke, 
tried alcohol, binge 
drinking and internet 
tobacco product 
advertising 
Current 
tobacco 
smoker 
aRR: 
1.43  
(95% 
CI: 
0.94-
2.16) 
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MacMillen, 
201951 
Prospective 
Cohort 
Population-
based 
Population 
Assessment 
of Tobacco 
and Health 
Study 
(PATH) 
USA 1 
 
2013-2015 
5762 Ever e-
cigarette use 
(Baseline) 
Never e-
cigarette, 
never 
tobacco 
users 
Tobacco 
initiation 
 
OR: 4.0  
(95% CI: 
2.60-6.10) 
race/ethnicity, sex, age, 
education, household 
smoking rules, and living 
with someone who 
smokes cigarettes. Past 30-day e-
cigarette use 
(Baseline) 
Tobacco 
initiation 
 
OR: 6.6  
(95% CI: 
3.7-11.8) 
Ever e-
cigarette use 
(Baseline) 
Current 
tobacco 
smoker 
OR: 2.5  
(95% CI: 
0.6-10.9) 
Past 30-day e-
cigarette use 
(Baseline) 
Current 
tobacco 
smoker 
OR: 8.0  
(95% CI: 
2.8-22.7) 
Miech, 201752 Prospective 
Cohort 
School-based 
Monitoring 
the Future 
study 
USA 1.12 
 
2015-2016 
246 Past 30-day e-
cigarette use 
(Baseline) 
No past 30-
day e-
cigarette 
use, never 
tobacco 
users 
Tobacco 
initiation 
 
RR: 4.78 
(95% CI: 
1.91-11.96) 
binge drinking, alcohol 
use, marijuana use, sex, 
ethnicity 
Morgenstern, 
201853 
Cluster 
randomized 
study 
School-based 
 Germany 0.5 
 
2015-2016 
2186 Ever e-
cigarette use 
(Baseline) 
Never e-
cigarette, 
never 
tobacco 
users 
Tobacco 
initiation 
RR: 2.18 
(95% CI: 
1.68-2.83) 
Sex, age, state, school, 
immigration status, 
parental education, SES, 
personality factors, 
substance use (alcohol, 
binge drinking, cannabis 
consumption, other 
illegal drugs) 
Penzes, 201854 Cluster 
randomized 
control trial 
School-based 
 Romania 0.5 
 
2014-2015 
707 Ever e-
cigarette use 
(Baseline) 
Never e-
cigarette, 
never 
tobacco 
users 
Tobacco 
initiation 
OR: 3.57  
(95% CI: 
1.96-6.49) 
Sex, age, waterpipe, 
intervention 
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Primack, 
201555 
Prospective 
Cohort 
Population-
based 
Dartmouth 
Media 
Advertising 
and Health 
Study 
USA 1 
 
2012-2014 
694 Ever e-
cigarette use 
(Baseline) 
Never e-
cigarette, 
never 
tobacco 
users 
Tobacco 
initiation 
OR: 8.3 
(95% CI: 
1.2-58.6) 
Age, sex, ethnicity, 
maternal education, 
sensation seeking, 
parental and peer 
smoking 
Primack, 
201856 
Prospective 
Cohort 
Population-
based 
Growth from 
Knowledge 
sample 
USA 1.5 
 
2013-2014 
915 Ever e-
cigarette use 
(Baseline) 
Never e-
cigarette, 
never 
tobacco 
users 
Tobacco 
initiation 
OR: 6.82 
(95% CI: 
1.65-28.25) 
Age, Sex, Ethnicity, 
relationship status, living 
situation, yearly 
household income, 
education, self-esteem, 
sensation seeking, 
rebelliousness 
Spindle, 
201757 
Prospective 
Cohort 
College-based 
Spit for 
Science 
(S4S) 
project 
USA 1 
 
2014-2015 
2316 Ever e-
cigarette use 
(Baseline), 
153 
Never e-
cigarette, 
never 
tobacco 
users 
Tobacco 
initiation 
OR: 3.37 
(95% CI: 
1.91-5.94) 
Sex, age, ethnicity, 
depression, anxiety, 
urgency, premeditation, 
perseverance, sensation 
seeking, stressful life 
events, peer deviance, 
other product use 
Ever e-
cigarette use 
(Baseline) 
Current 
tobacco 
smoker 
OR: 3.30 
(95% CI: 
1.20-9.05) 
Past 30-day e-
cigarette use 
(Baseline) 
Tobacco 
initiation 
OR: 3.41 
(95% CI: 
1.57-7.41) 
Past 30-day e-
cigarette use 
(Baseline) 
Current 
tobacco 
smoker 
OR: 1.15 
(95% CI: 
0.15-9.06) 
130 
 
 
 
Treur, 201858 Prospective 
Cohort 
School-
based 
Two Dutch 
cohorts 
(Cohort I 
and Tr&nds 
study 
cohort) 
Netherlands 0.5 
 
2014-2015 
2100 Ever e-
cigarettes 
with Nicotine 
(Baseline) 
Never e-
cigarette 
with 
nicotine 
Tobacco 
initiation 
OR: 11.90 
(95% CI: 
3.36-42.11) 
Sex, age, education, 
propensity to smoke 
Watkins, 
201759 
Prospective 
Cohort 
Population-
based 
Population 
Assessment 
of Tobacco 
and Health 
Study 
(PATH) 
USA 0.5 
 
2014-2015 
9909 Ever e-
cigarette use 
(Baseline) 
Never e-
cigarette, 
never 
tobacco 
users 
Tobacco 
initiation 
OR: 2.99  
(95% CI: 
1.98-4.53) 
female, age, 
race/ethnicity, parental 
educational 
level, urban residence, 
sensation seeking, 
alcohol ever use, living 
with tobacco 
user, notice of cigarette 
warning labels, tobacco 
advertising receptivity, 
and summer season 
Current 
tobacco 
smoker 
OR: 2.12 
(95% CI: 
1.11-4.03) 
Wills, 201760 Prospective 
Cohort 
School-
based 
 USA 1 
(2013-
2014) 
1070 Ever e-
cigarette use 
(Baseline) 
Never e-
cigarette 
users, never 
smokers 
Tobacco 
initiation 
OR: 2.87 
(95% CI: 
2.03-4.05) 
Age, gender, ethnicity, 
parental education, 
parental support and 
rebelliousness. 
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6.3.3 Risk of bias within studies 
Of the 24 articles included in this study, when assessing the risk of bias within studies using a 
modified Newcastle Ottawa Scale for cohort studies32 (Appendix 1) 20 were assessed as having a 
low risk of bias and 4 as high risk of bias. The main areas where points were lost were in terms 
of the ascertainment of exposure where the majority of studies had written or online self-reports, 
length of follow-up (minimum 1 year) and adequacy of follow up (Table 6.2).  
 
Table 6.2: Risk of bias within studies  
 
Article Selection  
(4 points) 
Comparability  
(1 point) 
Outcome  
(3 points) 
Risk of Bias 
Aleyan, 201829 3 1 2 Low 
Barrington, 201628 3 1 3 Low 
Barrington, 201839 3 1 2 Low 
Berry, 201940 3 1 3 Low 
Chien, 201941 3 1 3 Low 
Conner, 201842 3 1 3 Low 
Conner, 201943 3 1 3 Low 
East, 201844 3 1 1 High 
Hammond, 201745 4 1 2 Low 
Kinnunen, 201946 3 1 3 Low 
Kintz, 201947 4 1 2 Low 
Leventhal, 201548 3 1 2 Low 
Loukas, 201849 3 1 3 Low 
Lozano, 201750 4 1 2 Low 
MacMillen, 201951 4 1 3 Low 
Miech, 201752 3 1 3 Low 
Morgenstern, 201853 1 1 1 High 
Penzes, 201854 2 1 1 High 
Primack, 201555 3 1 3 Low 
Primack, 201856 3 1 3 Low 
Spindle, 201757 3 1 2 Low 
Treur, 201858 3 1 1 High 
Watkins, 201759 4 1 2 Low 
Wills, 201760 4 1 3 Low 
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6.3.4 Synthesis of results 
Ever e-cigarette use leading to tobacco initiation 
The longitudinal relationship between ever e-cigarette use at baseline and conventional tobacco 
smoking initiation at follow-up was assessed by 16 of the final studies.28,39-44,48,49,51,54-57,59,60 The 
pooled odds ratio of this relationship using a random effects model was statistically significant 
with individuals who ever used e-cigarettes at baseline being OR=3.28 times more likely (95% 
CI: 2.74-3.92; I2=62.91) to report the initiation of conventional tobacco smoking at follow-up 
(Figure 6.2). However, upon visual inspection of the funnel plot (Figure 6.3), there was a slight 
right skew at the base of the funnel plot suggesting potential for publication bias. However, when 
we tested for the potential presence of publication bias using Egger’s regression test (P-value 2-
tailed = 0.33 > 0.05), publication bias was not statistically significant.  
Ever e-cigarette use leading to current tobacco use 
A total of seven studies examined the longitudinal association between e-cigarette use at baseline 
and current conventional tobacco smoking (past 30-day conventional tobacco use) at follow-
up.39,40,43,46,51,57,59 A statistically significant association was found, with baseline ever e-cigarette 
users being OR=2.37 times more likely (95% CI: 1.48-3.77; I2=78.07) to become current tobacco 
users at follow-up compared to never e-cigarette and conventional tobacco users (Figure 6.4). 
When examining for potential publication bias using the funnel plot (Figure 6.5), we noted the 
studies were right skewed. This was confirmed with Egger’s regression test (p-value for 2-tailed 
test = 0.0049 < 0.05). The Duval and Tweedie’s trim and fill methodology was used to adjust for 
potential publication bias with the new effect measure using a random effects model being 
OR=1.89, 95% CI: 1.34-2.66; Q-Value = 28.43. Three studies were trimmed and added to the 
left of the mean (Table 6.3, Figure 6.6). 
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Study name Sample Size Statistics for each study Forest Plot 
  Odds ratio 95% CI p-value Odds ratio and 95% CI 
      
Barrington, 201628 298 4.29 1.84-10.00 < 0.01 
 
Barrington, 201839 6258 4.57 3.59-5.82 < 0.01 
Berry, 201940 6123 4.09 2.97-5.63 < 0.01 
Chien, 201941 12,954 2.14 1.66-2.75 < 0.01 
Conner, 201842 1726 4.06 2.94-5.60 < 0.01 
Conner, 201943 3994 2.78 2.20-3.51 < 0.01 
East, 201844 923 10.57 3.33-33.53 < 0.01 
Leventhal, 201548 2530 1.75 1.10-2.78 0.02 
Loukas, 201849 2558 2.26 1.35-3.77 < 0.01 
MacMillen, 201951 5762 4.00 2.61-6.13 < 0.01 
Penzes, 201854 707 3.57 1.96-6.50 < 0.01 
Primack, 201555 694 8.30 1.19-58.00 0.03 
Primack, 201856 915 6.82 1.65-28.22 0.01 
Spindle, 201757 2316 3.37 1.91-5.94 < 0.01 
Watkins, 201759 9909 2.99 1.98-4.52 < 0.01 
Wills, 201760 1070 2.87 2.03-4.05 < 0.01 
Pooled random effects estimate 3.28 2.74-3.92 < 0.01 
Figure 6.2: Random effects model examining the longitudinal association between ever e-cigarette use at baseline and subsequent 
tobacco initiation at follow-up 
  
Study name Subgroup within study Outcome Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
Barrington, 2016 Ever e-cigarette use Tobacco Initiation 4.29 1.84 10.00 0.00
Barrington, 2018 Ever e-cigarette use Tobacco Initiation 4.57 3.59 5.82 0.00
Berry, 2019 Ever e-cigarette use Tobacco Initiation 4.09 2.97 5.63 0.00
Chien, 2019 Ever e-cigarette use Tobacco Initiation 2. 4 1.66 2.75 0.00
Conner, 2018 Ever e-cigarette use Tobacco Initiation 4.06 2.94 5.60 0.00
Conner, 2019 Ever e-cigarette use Tobacco Initiation 2.78 2.20 3.51 0.00
East, 2018 Ever e-cigarette use Tobacco Initiation 10.57 3.33 33.53 0.00
Lev nthal, 2015 Ever e-cigarette use Tobacco Initiation 1.75 1.10 2.78 0.02
Loukas, 2018 Ever e-cigarette use Tobacco Initiation 2.26 1.35 3.77 0.00
MacMillen, 2019 Ever e-cigarette use Tobacco Initiation 4.00 2.61 6.13 0.00
Penzes, 2018 Ever e-cigarette use Tobacco Initiation 3.57 1.96 6.50 0.00
Primack, 2015 Ever e-cigarette use Tobacco Initiation 8.30 1.19 58.00 0.03
Primack, 2018 Ever e-cigarette use Tobacco Initiation 6.82 1.65 28.22 0.01
Spindle, 2017 Ever e-cigarette use Tobacco Initiation 3.37 1.91 5.94 0.00
Watkins, 2017 Ever e-cigarette use Tobacco Initiation 2.99 1.98 4.52 0.00
Wills, 2017 Ever e-cigarette use Tobacco Initiation 2.87 2.03 4. 5 0.00
3. 8 2.74 3.92 0.00
0.1 0.2 0.5 1 2 5 10
Favours A Favours B
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Figure 6.3: Funnel plot of standard error by log odds ratio; ever e-cigarette use at baseline and conventional tobacco initiation at 
follow-up 
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Study name Sample Size Statistics for each study Forest Plot 
  Odds 
ratio 
95% CI p-value Odds ratio and 95% 
CI 
      
Barrington, 201839 6258 3.51 1.97-6.25 < 0.01 
 
Berry, 201940 6123 2.75 1.60-4.73 < 0.01 
Conner, 201943 3994 1.27 1.17-1.39 0.03 
MacMillen, 201951 5762 2.50 0.59-10.66 0.215 
Spindle, 201757 2316 3.30 1.20-9.06 0.02 
Watkins, 201759 9909 2.12 1.11-4.04 0.02 
Kinnunen, 201946 1923 2.92 1.09-7.84 0.03 
Pooled random effects estimate 2.37 1.48-3.77 < 0.01 
 
Figure 6.4: Random effects model examining the longitudinal association between ever e-
cigarette use at baseline and subsequent current (past 30-day) tobacco use at follow-up 
 
Study name Subgroup within study Outcome Time point Statistics for each study O ds atio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
Barrington, 2018 Ever e-cigarette use Cur ent Tobacco 1.000 3.510 1.972 6.247 0.0 0
Berry, 2019 Ever e-cigarette use Cur ent Tobacco 2.000 2.750 1.599 4.728 0.0 0
Conner, 2019 Ever e-cigarette use urre t Tobacco 2.000 1.270 1.174 1.374 .000
MacMillen, 2019 Ever e-cigarette use Current Tobacco 1.000 2.500 0.587 10.656 0.215
Spindle, 2017 Ever e-cigarette use Current Tobacco 1.000 3.300 1.202 9.062 .021
Watkins, 2017 Ever e-cigarette use Current Tobacco 1.000 2.120 1.113 4.039 .022
Kinnunen, 2019 Ever e-cigarette use Current Tobacco 2.000 2.920 1.088 7.836 .033
2.367 1.485 3.773 0.0 0
0.1 0.2 0.5 1 2 5 10
Favours A Favours B
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Figure 6.5: Funnel plot of standard error by log odds ratio; ever e-cigarette use at baseline and current tobacco use at follow-up 
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Figure 6.6: Funnel plot of standard error by log odds ratio; ever e-cigarette use at baseline and current tobacco use at follow-up with 
Duval Trim and Fill correction (studies in black) 
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Table 6.3: Duval and Tweedie’s trim and fill adjustment to effect estimate between ever e-
cigarette use at baseline and current tobacco use at follow-up using a random effects model 
 
6.3.5 Additional analysis 
Ever e-cigarette use leading to tobacco initiation – Subgroup by follow-up time 
When stratifying baseline ever e-cigarette use and follow-up tobacco initiation by follow-up 
time, the association remained significant at each follow-up period; 6 months (n=3, OR=3.52, 
95% CI: 1.50-8.31; I2=79.1), 1 year (n=7, OR=3.77, 95% CI: 3.21-4.42; I2=15.05), 1.5 years 
(n=3, OR=3.26, 95% CI: 1.79-5.93; I2=36.01) and 2 years (n=3, OR=2.86, 95% CI: 2.04-4.02; 
I2=79.42). While the overall association using the random effects model became OR=3.56 (95% 
CI: 3.10-4.09; I2=62.91) when accounting for follow-up time (Figure 6.7). 
Ever e-cigarette use leading to current tobacco use – Subgroup by follow-up time 
When examining the longitudinal association between ever e-cigarette use at baseline and current 
tobacco use at follow up by conducting a subgroup analysis by follow-up time, the association 
persisted at 1 year (n=4, OR=2.85, 95% CI: 1.94-4.17; I2=0.00) and at 2 years (n=3, OR=1.98, 
95% CI: 1.03-3.80; I2=80.50). Overall, the association using the random effects model became 
OR=2.60 (95% CI: 1.87-3.61, I2=78.07) when accounting for follow-up time (Figure 6.8). 
 
 
 
 
139 
 
 
Study name Sample Size Follow-up 
(Years) 
Statistics for each study Forest Plot 
   Odds ratio 95% CI p-value Odds ratio and 95% CI 
East, 201844 923 0.5 10.57 3.33-33.53 < 0.01 
 
Leventhal, 201548 2530 0.5 1.75 1.10-2.78 0.02 
Penzes, 201854 707 0.5 3.57 1.96-6.50 < 0.01 
0.5 year follow-up effects estimate 3.52 1.50-8.31 < 0.01 
Barrington, 201839 6258 1.0 4.57 3.59-5.82 < 0.01 
Conner, 201842 1726 1.0 4.06 2.94-5.60 < 0.01 
MacMillen, 201951 5762 1.0 4.00 2.61-6.13 < 0.01 
Primack, 201555 694 1.0 8.30 1.19-58.00 0.03 
Spindle, 201757 2316 1.0 3.37 1.91-5.94 < 0.01 
Watkins, 201759 9909 1.0 2.99 1.98-4.52 < 0.01 
Wills, 201760 1070 1.0 2.87 2.03-4.05 < 0.01 
1-year follow-up effects estimate 3.76 3.21-4.42 < 0.01 
Barrington, 201628 298 1.5 4.29 1.84-10.00 < 0.01 
Loukas, 201849 2558 1.5 2.26 1.35-3.77 < 0.01 
Primack, 201856 915 1.5 6.82 1.65-28.22 0.01 
1.5-year follow-up effects estimate 3.26 1.79-5.93 < 0.01 
Berry, 201940 6123 2.0 4.09 2.97-5.63 < 0.01 
Chien, 201941 12,954 2.0 2.14 1.66-2.75 < 0.01 
Conner, 201943 3994 2.0 2.78 2.20-3.51 < 0.01 
2-year follow-up effects estimate 2.86 2.04-4.02 < 0.01 
Overall effects estimate  3.56 3.10-4.09 < 0.01 
Figure 6.7: Sub-group analysis by length of follow-up (0.5, 1.0, 1.5 and 2.0 years) using a random effects model examining the 
longitudinal association between ever e-cigarette use at baseline and tobacco initiation at follow-up 
  
Group by
Time point
Study name Subgroup within study Outcome Time point Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
0.50 East, 2018 Ever e-cigarette use Tobacco Initiation 0.50 10.57 3.33 3 .53 0.0
0.50 Leventhal, 2015 Ever e-cigare te use Tobacco Initiation 0.50 1.75 1.10 .78 .02
0.50 Penzes, 2018 Ever e-cigarette use Tobacco Initiation 0.50 3.57 1.96 .50 0.0
0.50 3.52 1.50 .31 0.0
1.00 Barrington, 2018 Ever e-cigarette use Tobacco Initiation 1.00 4.57 3.59 .82 0.0
1.00 Conner, 2018 Ever e-cigar tte use Tobacco Initiation 1.00 4.06 2.94 .60 0.0
1.00 MacMillen, 2019 Ever e-cigarette use Tobacco Initiation 1.00 4.00 2.61 .13 0.0
1.00 Primack, 2015 Ever e-c garette use Tobacco Initiation 1.00 8.30 1.19 58.00 .03
1.00 Spindle, 2017 Ever e-cigarette use Tobacco Initiation 1.00 3.37 1.91 .94 0.0
1.00 Watkins, 2017 Ever e-cigarette use Tobacco Initiation 1.00 2.99 1.98 .52 0.0
1.00 Wills, 2017 Ever e-cigarette use Tobacco Initiation 1.00 2.87 2.03 .05 0.0
1.00 3.76 3.21 .42 0.0
1.50 Barrington, 2016 Ever e-cigarette use Tobacco Initiation 1.50 4.29 1.84 10. 0 0.0
1.50 Loukas, 2018 Ever e-cigarette use Tobacco Initiation 1.50 2.26 1.35 .7 0.0
1.50 Primack, 2018 Ever e-cigarette use Tobacco Initiation 1.50 6.82 1.65 28.22 0.01
1.50 3.26 1.79 5.93 0.00
2.00 Berry, 2019 Ever e-cigarette use Tobacco Initiation 2.00 4.09 2.97 5.63 0.00
2.00 Chien, 2019 Ever e-cigarette use Tobacco Initiation 2.00 2.14 1.66 2.75 0.00
2.00 Conner, 2019 Ever e-cigarette use Tobacco Initiation 2.00 2.78 2.20 3.51 0.00
2.00 2.86 2.04 4.02 0.00
Overall 3.56 3.10 4.09 0.00
0.1 0.2 0.5 1 2 5 10
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Study name Sample 
Size 
Follow-up Statistics for each study Forest Plot 
   Odds ratio 95% CI p-value Odds ratio and 95% CI 
       
Barrington, 201839 6258 1 3.51 1.97-6.25 < 0.01 
 
MacMillen, 201951 5762 1 2.50 0.59-10.66 0.21 
Spindle, 201757 2316 1 3.30 1.20-9.06 0.02 
Watkins, 201759 9909 1 2.12 1.11-4.04 0.02 
1-year follow-up effects estimate 2.85 1.94-4.17 < 0.01 
Berry, 201940 6123 2 2.75 1.60-4.73 < 0.01 
Conner, 201943 3994 2 1.27 1.17-1.37 < 0.01 
Kinnunen, 201946 1923 2 2.92 1.09-7.84 < 0.01 
2-year follow-up effects estimate 1.98 1.03-3.79 0.04 
Overall effects estimate 2.60 1.87-3.80 < 0.01 
Figure 6.8: Sub-group analysis by length of follow-up (1.0, and 2.0 years) using a random effects model examining the longitudinal 
association between ever e-cigarette use at baseline and current tobacco use at follow-up 
 
Group by
Time point
Study name Subgroup within study Outcome Time point Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
1.00 Barrington, 2018 Ever e-cigarette use Current Tobacco .000 3.510 1.972 6.24 0. 00
1.00 MacMillen, 2019 Ever e-cigarette use Current Tobacco .000 2.500 0.587 10.6 6 . 5
1.00 Spindle, 2017 Ever e-cigarette use Current Tobacco 1.000 3.300 1.202 9.062 . 1
1.00 Watkins, 2017 Ever e-cigarette use Current Tobacco 1.000 2.120 .113 4.039 2
1.00 2.848 1.945 4.171 0. 00
2.00 Berry, 2019 Ever e-cigarette use Current Tobacco 2.000 2.750 1. 99 4.728 0. 00
2.00 Conner, 2019 Ever e-cigarette use Current T bacco 2.000 1.270 1.174 1.374 0. 00
2.00 Kinnunen, 2019 Ever e-cigarette use Current Tobacco 2.000 2.920 1.088 7.836 0. 33
2.00 1.982 1.034 3.798 39
Overall 2.596 1.868 3.60 0. 00
0.1 0.2 0.5 1 2 5 10
Favours A Favours B
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6.4 Discussion 
E-cigarette use is a growing public health concern, and there are different proposed hypotheses 
for how e-cigarette use leads to conventional tobacco initiation (addiction, accessibility and 
experience hypotheses).30 This systematic review and meta-analysis pooled data from 17 studies, 
16 of which examined the longitudinal relationship between ever e-cigarette use at baseline and 
conventional tobacco smoking initiation at follow-up, with a control group consisting of e-
cigarette and tobacco naïve participants28,39-44,48,49,51,54-57,59,60 and data from seven studies was 
pooled examining the effect of baseline ever e-cigarette use on follow-up current tobacco 
use.39,40,43,46,51,57,59 We used the most adjusted measures of association for the pooled meta-
analysis to determine the most conservative effect measure accounting for the most variability 
possible in the outcome measures (tobacco initiation and current tobacco use). 
Our results indicated statistically significant associations between ever e-cigarette use at baseline 
and tobacco initiation at follow up (Pooled OR=3.28, 95% CI: 2.74-3.92; I2=62.91) with 
moderate heterogeneity. Follow-up time contributed to this heterogeneity and we conducted a 
subgroup analysis. All time periods remained statistically significant and our results are 
consistent with previous studies.45,47,61,62 Interestingly, longer follow up periods had lower effect 
estimates. We found further evidence that ever e-cigarette use at baseline was a predictor of 
current tobacco use at follow up (Pooled OR=1.89, 95% CI: 1.34-2.66; Q=28.43) compared to 
tobacco and e-cigarette naïve respondents. These findings are troubling as there is evidence that 
baseline e-cigarette use increases susceptibility to conventional tobacco by both increased 
curiosity and willingness to initiate.63 Moreover, individuals susceptible to e-cigarettes have an 
increased risk of initiating conventional tobacco use after e-cigarette initiation.64 This study used 
ever e-cigarette use as the exposure of interest, and our findings show a relationship with tobacco 
initiation, this could mean similar to cigarettes with an estimated 69% of tobacco experimenters 
becoming temporarily a daily smoker after just 1 cigarette,65 e-cigarette vapor may possibly have 
similar effects that warrant further study.  
The e-cigarette use behaviour (ever use vs. past 30-day use) was an area we were unable to 
conduct a meta-analysis for, however the studies included in this study indicate that past 30-day 
e-cigarette users who were tobacco naïve were at greater risk of tobacco initiation29,45,51,52 with a 
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relative risk estimate of 4.78 (95% CI: 1.91-11.96)52 and adjusted odds ratios ranging from 2 to 
6.29,45,51,57 However, there was significant heterogeneity in the exposure assessment therefore we 
did not conduct a meta-analysis. We additionally wanted to examine the effects of e-cigarette use 
by sex to see if there are any differences in conventional tobacco initiation when comparing 
males to females however, we did not find any study stratifying based on sex, most were simply 
accounting for biological sex as a covariable, suggesting a gap in the literature that needs to be 
investigated. When examining the relationship between ever e-cigarette use at baseline and 
tobacco initiation at follow-up, we did not find evidence of small study effects or publication 
bias (Figure 6.3), and Egger’s test was not significant. We did have moderate heterogeneity 
though I2=62.91. These findings can be attributed to several factors such as length of follow-up, 
sample size, sociodemographic factors (geographical location, age, sex), and not having a 
timeframe of “ever e-cigarette use”. Furthermore, to attain the most conservative estimates we 
used the estimates from the most adjusted models reported. To best address heterogeneity in our 
meta-analysis, we used individuals defined as ever e-cigarette users who were never tobacco 
smokers as the baseline population. Our sub-group analysis showed high heterogeneity at 6 
months and 2 years follow-up (I2=79.1 and 79.42 respectively), but low heterogeneity at 1 year 
(I2=15.05) and at 1.5 years follow-up (I2=36.01) The results of ever e-cigarette use and future 
current conventional tobacco use had high heterogeneity (I2=78.07) and there was evidence of 
either small study size or publication bias requiring adjustment (Figure 6.6 and Table 6.3). The 
funnel plot was right skewed towards the base (Figure 6.5), but when conducting subgroup 
analysis, similar to with tobacco initiation, the heterogeneity at 1 year follow up was low 
(I2=0.00), while at 2 years was high (I2=80.50). These findings suggest future studies should 
account for follow-up time in the analysis when examining the effect of e-cigarette use on 
conventional tobacco behaviours and there may be additional factors influencing tobacco related 
behaviours at longer follow-up times. Two articles that examined the relationship between 
baseline ever e-cigarette use and tobacco initiation at follow-up had very wide confidence 
intervals44,55 but removing these studies did not significantly influence the final effect measure 
(Appendix 2).  
Health promotion and education campaigns, especially aimed at youth and young adults need to 
better increase awareness of the potential harms associated with e-cigarette use and their role as 
tobacco initiation devices, as currently there are many positive attitudes, beliefs and societal 
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norms surrounding e-cigarettes9-19 and they are not stigmatized like tobacco. Furthermore, policy 
makers need to restrict e-cigarette marketing and use similar to tobacco policies as there is 
evidence, they are being used to circumvent effective existing tobacco policies.65  
Study’s strengths and limitations: 
Strengths of this study included using a robust, reproducible and validated methodology, having 
sufficient recent longitudinal studies included to conduct a meta-analysis with a temporal 
component and providing up to date information and insights into an area of research that has 
conflicting opinions. All the studies included in our meta-analysis used tobacco and e-cigarette 
naïve control groups, and assessed e-cigarette use at baseline without having any ever tobacco 
users. Despite trying to standardize the exposure and outcome measurements, different studies 
have different adjustments for the outcome of interest (tobacco initiation or current tobacco 
initiation). In addition, the follow-up periods were different for different studies, but we tried to 
account for this in our subgroup analysis. Additionally, results are not necessarily generalizable 
because there are studies from different regions of the world. Most studies assessed the exposure 
and the outcome through self-reported questionnaires which may introduce bias. Finally, certain 
studies had a low number of e-cigarette users or conventional tobacco initiation which may result 
in over or underestimating the measure of effect in pooled analysis, however, our results are 
consistent with recently published literature and a previous meta-analysis. 
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6.5 Conclusions 
E-cigarettes are a growing public health concern. Our results suggest that there are potential 
future implications of the continued growth in e-cigarette uptake especially among youth as we 
found significant associations between baseline ever e-cigarette use and both conventional 
tobacco initiation and current tobacco use at follow-up. These findings suggest there is 
potentially an “intermediary” step in conventional tobacco uptake which could possibly lead to a 
new delayed-onset tobacco epidemic in the future leading to increased and unforeseen morbidity 
and mortality, circumventing effective tobacco cessation and control policies and educational 
initiatives. Current initiatives need to incorporate all smoking related behaviours, and not just 
focus on tobacco cessation as they are interlinked and share common risk factors as well as 
unique factors. Future research incorporating the dose of e-cigarettes, sex-based differences and 
nicotine content would be of immense value in characterizing the potential risks associated with 
e-cigarette use.  
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Appendix 1 – Modified Newcastle Ottawa Scale and Scoring 
Note: A study can be awarded a maximum of one star for each numbered item within the Selection and 
Outcome categories. A maximum of one star can be given for Comparability 
 
Selection 
1) Representativeness of the exposed cohort 
a) truly representative of the average _______________ (describe) in the community   
b) somewhat representative of the average ______________ in the community  
c) selected group of users eg nurses, volunteers 
d) no description of the derivation of the cohort 
2) Selection of the non exposed cohort (Control Group) 
a) drawn from the same community as the exposed cohort  
b) drawn from a different source 
c) no description of the derivation of the non exposed cohort  
3) Ascertainment of exposure 
a) secure record (eg surgical records or verified)  
b) structured interview  
c) written self report 
d) no description 
4) Demonstration that outcome of interest was not present at start of study 
a) yes  
b) no 
Comparability 
1) Comparability of cohorts on the basis of the design or analysis (i.e. analysis of covariables) 
a) study controls for age, sex, other tobacco products (select the most important factor)  
b) study controls for any additional factor   (This criteria could be modified to indicate specific                   
control for a second important factor.)  
Outcome 
1) Assessment of outcome  
a) independent blind assessment  
b) record linkage  
c) self report  
d) no description 
2) Was follow-up long enough for outcomes to occur (Minimum 1-year) 
a) yes (select an adequate follow up period for outcome of interest)  
b) no 
3) Adequacy of follow up of cohorts 
a) complete follow up - all subjects accounted for   
b) subjects lost to follow up unlikely to introduce bias - small number lost - > 20 % (select an adequate 
%) follow up, or description provided of those lost)  
c) follow up rate < 80% (select an adequate %) and no description of those lost 
d) no statement 
 
Low Risk of Bias: 3 or 4 stars in selection domain AND 1 star in comparability domain AND 2 or 3 stars 
in outcome/exposure domain  
Moderate Risk of Bias: 2 stars in selection domain AND 1 star in comparability domain AND 2 or 3 
stars in outcome/exposure domain  
High Risk of Bias: 0 or 1 star in selection domain OR 0 stars in comparability domain OR 0 or 1 stars in 
outcome/exposure domain
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Appendix 2 – Effect of one study removed; ever e-cigarette use and tobacco initiation 
 
Study name Sample Size Statistics with study removed Forest Plot 
  Odds ratio 95% CI p-value Odds ratio and 95% CI 
      
Barrington, 201628 298 3.25 2.71-3.91 < 0.01 
 
Barrington, 201839 6258 3.14 2.64-3.74 < 0.01 
Berry, 201940 6123 3.22 2.66-3.89 < 0.01 
Chien, 201941 12,954 3.42 2.89-4.05 < 0.01 
Conner, 201842 1726 3.22 2.66-3.89 < 0.01 
Conner, 201943 3994 3.35 2.75-4.09 < 0.01 
East, 201844 923 3.20 2.69-3.80 < 0.01 
Leventhal, 201548 2530 3.41 2.87-4.06 < 0.01 
Loukas, 201849 2558 3.36 2.79-4.04 < 0.01 
MacMillen, 201951 5762 3.23 2.68-3.91 < 0.01 
Penzes, 201854 707 3.27 2.71-3.94 < 0.01 
Primack, 201555 694 3.26 2.72-3.90 < 0.01 
Primack, 201856 915 3.25 2.71-3.89 < 0.01 
Spindle, 201757 2316 3.28 2.72-3.96 < 0.01 
Watkins, 201759 9909 3.31 2.73-4.01 < 0.01 
Wills, 201760 1070 3.33 2.74-4.04 < 0.01 
Overall random effects estimate 3.28 2.74-3.92 < 0.01 
This appendix details the influence of each study on the association between baseline ever e-cigarette use and follow up tobacco 
initiation.
Study name Subgroup within study Outcome Time point Statistics with study removed Odds ratio (95% CI) 
with study removed
Lower Upper 
Point limit limit p-Value
Barrington, 2016 Ever e-cigarette use Tobacco Initiation 1.500 3.252 2.707 3.907 0.000
Barrington, 2018 Ever e-cigarette use Tobacco Initiation 1.000 3.141 2.637 3.740 0.000
Berry, 2019 Ever e-cigarette use Tobacco Initiation 2.000 3.215 2.660 3.886 0.000
Chien, 2019 Ever e-cigarette use Tobacco Initiation 2.000 3.419 2.887 4.048 0.000
Conner, 2018 Ever e-cigarette use Tobacco Initiation 1.000 3.218 2.661 3.891 0.000
Conner, 2019 Ever e-cigarette use Tobacco Initiation 2.000 3.351 2.748 4.085 0.000
East, 2018 Ever e-cigarette use Tobacco Initiation 0.500 3.198 2.690 3.804 0.000
Leventhal, 2015 E er e-cigarette use Tobacco Initiation 0.500 3.412 2.870 4.056 0.000
Loukas, 2018 Ever e-cigarette use Tobacco Initiation 1.500 3.359 2.793 4.040 0.000
MacMillen, 2019 Ever e-cigarette use Tobacco Initiation 1.000 3.234 2.678 3.905 0.000
Penzes, 2018 Ever e-cigarette use Tobacco Initiation 0.500 3.269 2.711 3.941 0.000
Primack, 2015 Ever e-cigarette use Tobacco Initiation 1.000 3.255 2.721 3.895 0.000
Primack, 2018 Ever e-cigarette use Tobacco Initiation 1.500 3.245 2.711 3.885 0.000
Spindle, 2017 Ever e-cigarette use Tobacco Initiation 1.000 3.279 2.718 3.957 0.000
Watkins, 2017 Ever e-cigarette use Tobacco Initiation 1.000 3.311 2.734 4.009 0.000
Wills, 2017 Ever e-cigarette use Tobacco Initiation 1.000 3.3 8 2.742 4.038 0.000
3.279 2.743 3.920 0.000
0.1 0.2 0.5 1 2 5 10
Favours A Favours B
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7. CHAPTER 7: CONCLUSION 
The purpose of this thesis was to examine Canadian smoking related behaviours, specifically the 
different types of nicotine products available (conventional tobacco cigarettes, flavoured tobacco 
products and e-cigarettes), their prevalence, determinants, negative health outcomes and their 
dynamic complementarity.  
This thesis has addresses priority research areas that have a dearth of knowledge or lack of 
consensus and incorporates sex and gender considerations where applicable.  
Chapter 3 examined the prevalence and determinants of flavoured tobacco among youth, a 
rapidly growing phenomenon.  
Chapter 4 assessed the prevalence and identified determinants associated with conventional 
tobacco cigarette use among the Canadian LGB community. Lesbians and bisexuals were 
identified as a vulnerable population disproportionately affected by the tobacco epidemic. 
Chapter 5 assessed the prevalence of COPD by past 30-day e-cigarette use among individuals 
from Ontario, British Columbia, Nova Scotia and the Northwest Territories, and quantified the 
association between e-cigarette use and COPD and identified sex-based effects modification.  
Chapter 6 was a systematic review and meta-analysis which found the use of e-cigarettes leads to 
conventional tobacco initiation over time using the most up to date data from published 
longitudinal studies. 
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7.1 Major findings 
This thesis investigated various aspects of smoking related behaviours. From identifying 
determinants and risk profiles among vulnerable populations (Canadian high school students for 
flavoured tobacco and the Canadian LGB population for conventional tobacco smoking), health 
outcomes due to novel nicotine delivery devices (the association between e-cigarettes and 
COPD) and what the relationship is between e-cigarette use and conventional tobacco initiation. 
Taken together, this thesis discusses aspects related to smoking behaviours in the epidemiology, 
health promotion and policy implications. 
Chapter 3 (Prevalence and characteristics of flavoured tobacco use among students in grades 
10 through 12) provided a framework to identify individuals at highest risk of flavoured tobacco 
use, which was purported to be easier to initiate, a safer alternative to conventional tobacco 
cigarette and a tobacco cessation device.1 A weighted logistic regression analysis was carried out 
using the national, generalizable survey the Youth Smoking Survey (YSS) (2012-2013), and we 
developed our own flavoured tobacco use outcome variable (menthol cigarette or flavoured little 
cigar or cigarillo or flavoured cigar or flavoured tobacco in a water-pipe [hookah]) that was since 
adopted by the Canadian Student Tobacco, Alcohol and Drugs Survey (CSTADS, which is the 
continuation of the YSS) with the addition of smokeless tobacco and is being used in flavoured 
tobacco surveillance. Independent variables explored in this study included sex, grade, ethnicity, 
number of friends who smoke, sibling smokers, parent/guardian who smoke and weekly personal 
spending. Interestingly parental/guardian smoking was not significant upon logistic regression 
analysis, this suggests that adolescents are more influenced by their age group at least in terms of 
risky behaviours. Furthermore, contrary to studies from the US, ethnic differences among 
students in grade 10-12 was barely significant with individuals of Asian descent having 35% 
lower rates of flavoured tobacco use compared to students reporting White as their ethnic 
background. Males had a stronger association with flavoured tobacco use which may be 
attributed to increased risk taking behaviours and easier accessibility to purchase flavoured 
tobacco cigarettes. The strongest association with flavoured tobacco use in our study was 
situational factors, in this case peer use (number of friends and siblings who smoke). 
Furthermore, contrary to most population based studies that find lower socioeconomic status 
leads to worse outcomes, in this study students who had more than $100/week in spending 
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money were more likely to partake in flavoured tobacco use, with a graded increase as weekly 
spending increased. Since this study was published, the Canadian government has banned all 
flavoured tobacco as of 20182 and the impact of this ban remains to be seen, maybe students will 
decrease smoking related behaviours or there could be a shift towards electronic cigarettes which 
have a lot of commonalities with flavoured tobacco and are marketed similarly. 
Chapter 4 (Sexual orientation and smoking preferences results from a population-based survey 
in Canada 2009-2014) explored whether sexual orientation is independently associated with 
conventional tobacco smoking, and identified and characterized the Canadian lesbian/gay and 
bisexual (LGB) community, results of which provided important sex and gender implications 
when it comes to conventional tobacco use.  To the best of our knowledge, this was the first 
Canadian population-based study examining the relationship between sexual orientation and 
conventional tobacco use and this is partially attributed to the low prevalence of self-reported 
sexual minorities, thus we merged several survey cycles to create a large enough sample to 
analyze. Overall, the prevalence of conventional tobacco users was higher among all sexual 
minority groups compared to heterosexuals. This is unsurprising as they are a highly vulnerable 
population that has been targeted by the tobacco industry. A major finding was that the term 
“LGB” is not indicative of these unique and heterogenous populations. While the lesbian and gay 
population was majority male, older, former smokers, highly educated with good mental health, 
the bisexual population was majority female, young, current smokers, poorly educated and with 
higher rates of poor mental health. Both populations had different risk profiles for conventional 
tobacco use and health education and promotion efforts should be tailored appropriately rather 
than broadly collapsing them into one group. This study used a nominal multinomial regression 
approach, in other words the outcome variable (smoking status) had three levels (current or past 
30-day, former and never smokers). Our final model found differences in smoking status by 
sexual orientation among biological females but not among biological males which was another 
interesting finding adding more evidence to the literature. In other words, there was no 
statistically significant difference in smoking status among males whether they were 
heterosexual, gay or bisexual. Among biological females though, bisexuals and lesbians were 
more likely to be current or former rather than never smokers when compared to heterosexual 
females. This may be partially attributed to the dual disadvantage theory, whereby they are 
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disadvantaged both due to their biological sex (female) as well as their sexual orientation 
(bisexual or lesbian).3  
Chapter 5 (Examining the prevalence and association between e-cigarette use and chronic 
obstructive pulmonary disease in Canada: a cross-sectional study) is a population-based study 
using data from Ontario, British Columbia, Nova Scotia and the Northwest Territories examining 
whether an association exists between e-cigarette use and COPD. Furthermore, it adds additional 
evidence with respect to dual use behaviours.  In this chapter we identified COPD as a negative 
health outcome independently associated with e-cigarettes, adding evidence to existing proposed 
mechanisms in in vitro and animal studies. This study is exploratory in nature and cross-sectional 
therefore we cannot infer cause and effect from our results. Interestingly the prevalence of 
COPD among e-cigarette users was higher than that among conventional tobacco users however, 
there is significant overlap between the two with the majority of past 30-day e-cigarette users 
also being dual current tobacco users. This may be due to increased nicotine dependence and 
exposure or due to switching to reduce tobacco use. The majority of e-cigarette users were in the 
younger age group, while current tobacco users were in the middle-age group. Sex-based 
differences were identified in this study and similar to tobacco studies, female past 30-day e-
cigarette users reported significantly higher rates of COPD compared to male past 30-day e-
cigarette users. In addition, a sex-based effect modifier was significant where female past 30-day 
e-cigarette users had a more pronounced odds of COPD compared to female non e-cigarette 
users. While among males the difference based on past 30-day e-cigarette use was still 
significant, the odds were lower. This may be due to differential nicotine metabolism as female 
tobacco smokers require less of a dose to develop COPD symptomology and requires further 
investigation. Our exploratory analysis of dual e-cigarette and tobacco behaviours (dynamic 
complementarity) found that individuals who are dual users were more likely to report COPD, 
suggesting that there might be an additive or synergistic effect of using e-cigarettes and 
conventional tobacco, however as this study is cross-sectional, further studies are required to 
ascertain this finding. 
Chapter 6 (E-cigarettes as tobacco initiation devices: A systematic review and meta-analysis) 
added a temporality component to this thesis and examined the dynamic complementarity 
between initial e-cigarette use leading to tobacco initiation. As e-cigarettes were introduced 
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globally in 2007, in order to determine temporality and causality longitudinal studies are 
required. This chapter addressed this gap by incorporating data from 17 studies which were 
collected between 2012-2016 and published between 2015-2019. The PRISMA-P guidelines 
were followed, and pooled meta-analysis indicated that baseline ever e-cigarette use was 
associated with follow-up conventional tobacco initiation and current (past 30-day) tobacco 
initiation from a cohort of never-smokers. A major strength of this study is that the control group 
was consistent (never conventional tobacco users, never e-cigarette users), the exposure was 
consistent (ever e-cigarette use). One of the issues encountered was follow-up time which varied 
from six months to two years in the longitudinal studies, as a result a sub-group analysis was 
conducted incorporating follow-up time and results remained consistent with e-cigarette use 
remaining associated with follow-up tobacco initiation amongst all the groups.  
Figure 7.1 details the major findings of this thesis and how they are inter-connected in addressing 
the tobacco epidemic from different points of entry which include: 1) identifying determinants of 
vulnerable populations who are at greater risk of tobacco use; 2)   identifying morbidities 
associated with e-cigarette use; and 3) identifying the relationship between e-cigarette use and 
the initiation of conventional tobacco smoking. As tobacco use is the leading cause of premature 
death worldwide4 and has serious adverse effects such as COPD,5 which is predicted to be the 
third leading cause of death worldwide,6 using a multifaceted approach to address evolving 
smoking related behaviours and identifying possible health risks is necessary.
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Figure 7.1: Summary of major findings and inter-relatedness of this thesis. Chapter 3 examined determinants of flavoured tobacco 
smoking among youth. Chapter 4 examined determinants of LGB smoking at the population level. Chapter 5 examined the association 
between e-cigarette use and COPD. Chapter 6 examined e-cigarettes as conventional tobacco initiation devices. Yellow arrows denote 
areas examined in this thesis. Black arrows denote known effects of conventional tobacco use. 
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7.2 Policy implications and future research 
Findings from this thesis have implications in health promotion and education strategies, policy 
planning, evaluation and implementation and future research directions. It is important to note 
that smoking related behaviours are constantly evolving. In the 2010s flavoured tobacco was the 
major risky behaviour appealing to youth, but since the ban in 2018, flavoured tobacco has 
peaked as a smoking related behaviour. Going forward into the 2020s, the unchecked growth of 
e-cigarettes may lead to a delayed onset neo-tobacco epidemic. Similar strategies to recruit youth 
and vulnerable populations towards flavoured tobacco use in the past are currently being 
employed in e-cigarette recruitment. There is evidence of potential health consequences 
associated with e-cigarettes however, knowledge and perceptions among the general population 
are lacking. Vision and leadership by public health professionals, in research, health promotion, 
and education campaigns and in developing and evaluating comprehensive tobacco control and 
prevention policies incorporating all forms of smoking related behaviours are necessary. Failure 
to do so may result in e-cigarettes being a tool to circumvent global tobacco control strategies. 
In alignment with the new requirements of the Canadian Institute for Health Research, this thesis 
incorporated sex and gender considerations throughout and found further evidence that they play 
a key role in conventional tobacco smoking (Chapter 4), and influence health outcomes (Chapter 
5). As such, future research examining smoking behaviours by health outcomes and 
characterizing different sub-populations should incorporate sex and gender considerations where 
applicable. While the LGB population are sexual minority groups, there is no gender identity 
variables in national health surveys. As stigmatization continues to decrease, further studies on 
unique gender identity groups will be worthwhile and better determine what groups are at greater 
risk and allow health promotion efforts to be tailored accordingly. 
Research into e-cigarettes is ongoing and there are a lot of avenues to pursue. One of the major 
limitations of Chapter 5 was that we were unable to assess the association between past 30-day e-
cigarette users who never used conventional tobacco and COPD due to low sample size. As the 
Canadian population continues to age, more e-cigarette users will enter the younger age groups 
permitting this association to be tested. Additionally, studies examining e-cigarettes tend to use 
past 30-day e-cigarette use and/or ever e-cigarette use as indicators. Nicotine content of e-
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cigarette use is an important risk factor that has not been strongly studied as of yet and should be 
assessed in future research. Moreover, there is a need to develop a standardized description of e-
cigarette use, a framework like that of tobacco use. With tobacco use the definitions are clear, a 
never smoker, never smoked, an experimental smoker smoked less than 100 cigarettes in their 
lifetime and none in the past 30 days, a former smoker smoked more than 100 cigarettes in their 
lifetime but none in the past 30 days, and a current smoker smoked more than 100 cigarettes in 
their lifetime but not in the past 30 days. There is no equivalence for e-cigarette use yet, the best 
measures are ever use and past 30-day use, but magnitude and length of use need to be 
standardized for future research. An additional area that needs more research is the growth of 
dual use between e-cigarettes and conventional tobacco use. This thesis shows that dual users 
had the highest association with COPD. This group is replacing single product users and might 
potentially have worse morbidity due to increased exposures to nicotine and related content or 
switching products due to perceived harm reduction. Research needs to be conducted to 
determine why the sudden growth in dual use, is it a reaction to existing tobacco control policies, 
social norms or are dual users the most addicted to nicotine and what is the harm reduction 
potential. Finally, while we documented the association between ever e-cigarette use and tobacco 
initiation, it would be worthwhile for future research to examine past 30-day e-cigarette use and 
tobacco initiation as well as what is the association between e-cigarette use and tobacco initiation 
among males and females to look for any disparities.  
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7.3 Strengths and limitations 
A strength of this thesis is the novelty of tobacco related products under study. As a result, it 
provides additional insights into smoking related behaviours and the prevalence of alternative 
tobacco products (flavoured tobacco and e-cigarettes). One of the limitations of this thesis was 
the amount of data available, whether on the LGB population (Chapter 4), or e-cigarette use 
(Chapter 5 & 6). To account for limited data from the LGB population we used a pooled 
approach to maximize the sample size and improve our estimates. With respect to e-cigarette use, 
the model diagnostics indicated good fits and the findings while exploratory are timely and 
relevant. In chapter 5 due to data limitations, we were unable to ascertain the association 
between never smokers who were past 30-day e-cigarette users with COPD, this is due to data 
and time limitations (e-cigarettes only became available in 2007). E-cigarettes are still a new and 
developing nicotine delivery system and uptake is mostly by youth and young adults therefore it 
will require time before chronic diseases and cancer effects can be thoroughly characterized at 
the population level, however, identifying e-cigarette use behaviours early can help inform 
public health practices to try and prevent future negative health outcomes. In chapter 6 we did 
not have sufficient evidence to do a meta-analysis of the longitudinal association between past 
30-day e-cigarette use and tobacco initiation. Not many longitudinal studies assessed past 30-day 
e-cigarette use which might be useful in examining the dose response of e-cigarette exposure, 
nicotine addiction and future tobacco smoking. Another limitation of chapters 3-5 was using 
cross-sectional data. We are unable to infer causality only association, but our major findings are 
either biologically plausible, clinically relevant and/or consistent with previous studies, 
providing additional evidence in the field of smoking behaviours from a Canadian perspective.   
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